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i. Abstract 
 
Asymmetric reduction of N-aryl ketimines 189a-j, 212, and 213 with trichlorosilane can 
be catalyzed by new N-methyl L-amino acid-derived Lewis-basic organocatalysts, such as 
bisamide 197c (10 mol%), in toluene at room temperature with high enantioselectivity 
(≤92% ee). The structure-reactivity investigation shows that the product configuration is 
controlled by the nature of the side chain of the catalyst scaffold (e.g., i-Pr vs Me, as in 
197c  and  208c),  so  that  catalysts  of  the  same  absolute  configuration  may  induce  the 
formation of the opposite enantiomers of the product. Arene-arene interactions between 
the  catalyst  and  the  incoming  imine  appear  to  be  the  prerequisite  for  asymmetric 
induction. This metal-free, organocatalytic protocol is competitive with the traditional, 
metal-catalyzed methodology. 
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iii. Abbreviations 
 
 
Å      Angstrom 
Aq      Aqueous 
BINOL      1,1’-Binaphthol 
Bn      Benzyl 
Boc      tert-Butoxycarbonyl 
Bp      Boiling Point 
tert-Bu      Tertiary butyl 
Bz      Benzoyl 
oC      Degrees centigrade 
cat      Catalytic 
CI      Chemical ionisation 
cm      Centimetre 
conc      concentrated   
Cy      Cyclohexyl 
d      doublet (NMR spectroscopy) 
DMAP      4-Dimethylaminopyridine 
DMF      Dimethylformamide 
DMSO      Dimethylsulfoxide 
ee      Enantiomeric excess 
EI      Electron Impact 
Equiv      Equivalents 
GC      Gas Chromatography 
h      Hours 
HCN      Hydrogen Cyanide 
HPLC      High Performance Liquid Chromatography 
Hz      Hertz 
IR      Infrared 
M      Molarity 
m      Multiplet (NMR spectroscopy) 
min(s)      Minutes 
MS      Mass Spectroscopy 
Naph      Napthyl 
NMO      N-methylmorpholine-N-oxide 
NMR      Nuclear Magnetic Resonance 
PMP      para-Methoxyphenyl 
q      Quartet (NMR spectroscopy) 
rt      Room temperature 
satd      Saturated 
t      triplet (NMR spectroscopy) 
TLC      Thin Layer Chromatography 
UV      Ultraviolet   8 
Chapter 1:  Introduction 
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1.1 Introduction to Asymmetric Organocatalysis 
 
The area of organocatalysis, although not always known as this, has been around for the 
past 40 years.  In 1998 Professor David MacMillan, then of the University of California, 
Berkeley became interested in and developed a new concept that was based around small 
organic catalysts.  At this time he had been working on an enantioselective organocatalytic 
Diels  Alder  reaction  based  on  iminium-activation 
1  (scheme  1)  and  was  sure  he  had 
developed a new system of catalysis that could be used in many different transformations.  
He is quoted as saying: 
“I became interested in coining a new name for what was commonly referred to as „metal-
free catalysis‟.  My motivations for doing so were very simple.  I do not like the idea of 
describing an area of catalysis in terms of what it is not, and I wanted to invent a specific 
term  that  would  set  this  field  apart  from  other  types  of  catalysis.    The  term 
„organocatalysis‟ was born and a field that had existed for at least 40 years acquired a 
new name” 
2 
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Scheme 1 Organocatalytic Diels Alder process 
 
Although  it  has  been  around  for  40  years,  organocatalysis  is  still  very  much  in  its 
developmental  stage  and  as  such  new  organocatalytic  processes  are  appearing  in  the 
literature in an almost daily basis.  The requirement from the pharmaceutical industry for 
enantiomerically pure building blocks, free from impurities, has spurred many researchers 
to begin investigations into new organocatalytic methods.  However, competing with the 
equivalent metal-mediated or enzyme catalysed process is no mean feat and as such much 
effort and time has been dedicated by investigators to this problem. 
   10 
It has long been understood that only manufactured transition-metal based catalysts can be 
used  to  obtain  either  one  of  the  two  enantiomers  of  an  asymmetric  reaction  whereas, 
enzymes are specific only for one enantiomer.  Of course, enzymes can be altered by way 
of mutations but this is not too practical for a synthetic chemist!  In between the areas of 
Organocatalysis could be described as the area of catalysis that utilises only „organic‟ 
molecules made up of, in the main, carbon, hydrogen, nitrogen, sulphur and phosphorus to 
obtain the enantioselective outcome.  Organocatalysts, unlike the organic ligands that are 
associated  with  transition  metal  complexes  utilises  the  intrinsic  chirality  and  low 
molecular weight that they possess to great effect without the need for metals.  The one 
major  advantage  of  organocatalysts  over  transition  metal  derived  catalysts  and  indeed 
enzymes is cost.  Organocatalysts can be produced from inexpensive and readily available 
starting materials such as amino acids.  Also, organocatalytic methods would seem to be 
of particular interest to the pharmaceutical industry in that it would eliminate the problem 
of metal leaching in drug compounds. 
 
There are numerous different types of organocatalyst and some are shown in Figure 1.  
Many  of  these  molecules  stem  from  a  „chiral  pool‟  synthesis,  where  the  enantiopure 
compound is synthesised from a readily available enantiopure substance.  The chirality is 
then preserved in the final compound.
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Figure 1 Selection of organocatalyst motifs 
 
Although still in its formative years, the range of asymmetric reactions that can now be 
carried out organocatalytically is enormous.  Reactions such as substitution at aliphatic 
carbons (i.e. chlorination, bromination), nucleophilic addition to C=N double bonds (i.e. 
Strecker reaction, Mannich reaction), oxidations (i.e. alcohol oxidation, epoxidation of 
olefins)  and  reduction  of  carbonyl  and  imine  compounds.    Some  examples  of  the 
aforementioned reactions will be described below to give a glimpse of the practical scope 
of organocatalysis. 
   11 
1.1.1 Substitution at Aliphatic Carbons 
 
The enantioselective C-Cl bond forming reaction has recently been reported by Leckta et 
al. 
4 He has shown that the asymmetric -chlorination of cheap and readily available acid 
chlorides,  mediated  by  a  chinchona  alkaloid-derived  catalyst  1  can  produce  highly 
optically enriched -chloroesters (scheme 2).  The process occurs by the chiral alkaloid 
reacting with an in-situ generated ketene to form a zwitterionic enolate species.  To obtain 
high yields as well as high enantioselectivity, it was important to generate the ketene via 
the  basic  resin-bound  BEMP  3,  a  highly  basic  reagent  attached  to  a  Merrifield  resin.  
Without  this,  although  enantioselectivities  were  high,  the  reactions  were  low  yielding 
(≤40%).  Reaction with an electrophilc halogen 2 then furnishes the desired product.  The 
reaction mechanism is shown in scheme 3. 
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Scheme 2 General reaction scheme for -chlorination 
 
The use of benzoylquinine 1 as the chiral alkaloid and the halogenation agent 2 furnished 
-chloroesters (cf 5) in yields of ≤81% and ee‟s of ≤99%.  (Scheme 3) 
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Scheme 3 Mechanism for -chlorination 
 
This is not limited just to the chlorination reaction but -bromination reactions can also be 
carried out by simply altering the halogenation agent to effect bromination rather than 
chlorination 11.   
Br
Br
O
Br
Br
11  
 
1.1.2 Nucleophilic Addition to C=N Double Bonds 
 
1.1.2.1 Strecker Reaction 
 
An efficient method for producing -amino acids is to perform the Strecker reaction.  This 
involves reaction of an aldehyde with ammonia and a cyanide source such as hydrogen 
cyanide (HCN).  However, with regards to an asymmetric version, a more popular method 
involves  the  nucleophilic  addition  of  HCN  or  trimethylsilyl  cyanide  (TMSCN)  to  a 
preformed imine to furnish the amino nitrile (scheme 4).     13 
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Scheme 4 Asymmetric Strecker reaction. 
 
There are various metal-derived catalysts used to effect this transformation (figure 2) but 
more recently a range of organocatalysts have been developed to produce the same result 
(figure 2). 
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Figure 2 Examples of metal based catalysts for the asymmetric Strecker reaction 
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Some examples of organocatalysts that have been developed for this reaction are catalysts 
based on ureas 16, chiral guanidines 17 and diketopiperazines 18.   
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The chiral ureas  are  effective over a wide  range of substrates  (aromatic, aliphatic and 
cyclic) with enantioselectivities of ≤99% and in excellent yields.  Jacobsen et al
 6 reported 
a urea catalyst based on phenylalanine and a substituted salicaldehyde 19 which could 
effect the Strecker reaction on a wide range of aromatic and alkyl imines with ee‟s of 
≤99% and yields of ≤99%.     14 
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This  catalyst  also  proved  efficient  in  the  cyanation  of  cyclic  imines.    Imine 20  was 
cyanated with 19 in 91% ee and 88% yield. 
7  
 
N
20  
Corey et al
 8 in 1999 reported the use of C2-symmetric guanidine derived ligands 7 for the 
synthesis of chiral -amino nitriles from simple aromatic aldimines.  The reaction of a 
simple benzaldehyde derived aldimines with HCN and in the presence of 10 mol% of 
guanidine catalyst 21, afforded the corresponding amino nitrile in 96% yield and in 86% 
ee (scheme 5).  A proposed reaction mechanism is shown in scheme 6. 
 
N
N
H
N
R R
21 (10 mol%) N HN
CN
H
HCN, Toluene, -40oC, 20 h
22 23
 
Scheme 5 Asymmetric Strecker reaction with chiral guanidine catalyst 21 
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Scheme 6 Proposed reaction mechanism for the asymmetric Strecker reaction  
 
The Lipton group 
9 reported in 1996 the use of a cyclic diketopiperazines 26 as a catalyst 
in the asymmetric Strecker amino acid synthesis.  Using the same substrate as shown in 
scheme 5 (Corey), Lipton was able to obtain enantioselectivities in excess of 99% and in 
almost quantitative yields.  He also obtained similar results with a range of other aromatic 
substrates.  It should be noted however, that the system was poor at inducing chirality in 
heteroaromatic  and  aliphatic  substrates  giving  enantioselectivities  of  32%  and  17% 
respectively. 
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1.1.2.2 Mannich Reaction 
 
The  Mannich  reaction  is  probably  the  most  popular  method  for  producing  -amino 
carbonyl compounds.  It is a three component reaction consisting of an aldehyde, ketone 
and amine which react in one pot to form the -amino carbonyl compound.  The general 
reaction scheme is shown below (scheme 8).  
 
   16 
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Scheme 8 General reaction scheme for the Mannich reaction 
10 
 
List et al 
11 reported the first asymmetric three-component Mannich reaction catalysed by 
proline.  He showed that -amino ketones could be synthesised with either one or two 
stereogenic centres (scheme 9), depending on the starting ketone used with ee‟s of ≤99% 
and in excellent yields.  Although proline loading was quite high (35 mol%), the low cost 
and availability of the proline along with the fact that the catalyst could be recovered 
simply by filtration after the reaction was complete made this an attractive system. 
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Scheme 9 Asymmetric proline catalysed Mannich reaction 
 
The above examples represent the direct Mannich reaction (mechanism of (a) shown in 
scheme 10).     17 
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Scheme 10 Mechanism for asymmetric Mannich reaction 
 
However,  there  are  examples  of  the  indirect  Mannich  reaction  in  which  the  -amino 
ketones are formed via nucleophilic addition of enolates to preformed imines.  Jacobsen et 
al 
12 reported the use of a thiourea containing Schiff base 39 to catalyse this process.  
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Although he had developed this type of catalyst for the asymmetric Strecker reaction (see 
section 1.2.1) he found that using 5 mol% of 39 in the asymmetric nucleophilic addition of 
a  silyl  ketene  acetal  to  a  preformed  N-Boc-imine  could  lead  to  the  required  -amino 
ketone in enantioselectivities of ≤97% and yields of up to 95% (scheme 11).  
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Scheme 11 Nucleophilic addition of a silyl ketene acetal to a preformed N-Boc-imine 
 
1.1.3 Oxidations 
 
1.1.3.1 Alcohol Oxidation 
 
One way of resolving racemic alcohols is via kinetic resolution.  This is a process by 
which the differing reaction rates of individual enantiomers with a scalemic reagent are 
exploited.  The reaction, whatever that may be, is carried out to completion on the more 
reactive enantiomer whilst the less reactive enantiomer remains unchanged.  These two 
products  can now be easily separated leaving an enriched enantiomer and some other 
product.  Catalytic oxidation of alcohols with a chiral catalyst is a way of performing 
kinetic resolution on racemic alcohols.  A chiral derivative of a catalyst such as TEMPO 
43,  a  nitroxyl  radical,  used  alongside  hypochlorite  or  peroxyacetic  acid  (as  the  final 
oxidizing agent) can affect the oxidation of alcohols to carbonyls compounds. 
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Me
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An analogue of TEMPO was developed by Rychnovsky et al 
13 in 1996.  This binapthyl-
derived TEMPO 44 analogue was used in the kinetic resolution of a variety of racemic 
alcohols with ee‟s of recovered alcohols peaking at 98% (for 1-phenyl ethanol).  The 
reaction was carried out with a catalyst loading of 1 mol% (with 0.6 equivalents of sodium 
hypochlorite  used  as  the  final  oxidising  agent).    This  method  of  kinetic  resolution  is 
particularly attractive owing to the low catalyst loadings and use of commercial bleach as 
the oxidising agent.   19 
N O
44  
 
1.1.3.2 Epoxidation 
 
The  wide  use  of  chiral  epoxides  in  the  pharmaceutical  industry  as  intermediates  to 
enantiomerically pure building blocks has prompted researchers to spend much effort in 
developing more efficient protocols for epoxidation.   Sharpless et al 
14 has found great 
success  in  the  field  of  transition-metal  catalysed,  utilising  titanium  in  the  asymmetric 
epoxidation of allylic alcohols (scheme 12).  This is however limited to allylic alcohols 
(and some homoallylic alcohols) and works best for trans-olefins.  
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Scheme 12 Asymmetric epoxidation of allylic alcohols using Titanium (IV). 
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The epoxidation of unfunctionalised alkenes can also be achieved using (salen)Mn(III) 
catalysts 47.  Jacobsen et al 
16 reported the use of the aforementioned catalysts with a 
variety  of  alkenes  and  reaction  conditions,  with  varying  enantioselectivities  observed 
(works best for cis-olefins). 
N
O R2
N
O R2
R1 R1
Mn
Cl
47  
Jacobsen  found  that  when  R1  =  Ph  and  R2  =  OSi(i-Pr)3,  the  epoxidation  of  cis--
methylstyrene proceeded with 98% enantioselectivity (scheme 13). 
   20 
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Scheme 13 Catalytic epoxidation of cis--methylstyrene with (salen)Mn(III) catalyst. 
 
At present, organocatalytic protocols rely on dioxiranes 50, generated from chiral ketones 
51, as chiral epoxidising agents.  
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One  of  the  most  useful  chiral  ketones  available  is  the  Shi  ketone 52.
17  This  is  an 
inexpensive ketone prepared from D-Fructose and then functionalised in 2 simple steps 
(ketalization and then oxidation) to furnish the desired ketone.  The dioxiranes 53 are 
generated in situ from Oxone (potassium peroxomonosulfate) and the ketone x which then 
react with the alkene substrate 54 (scheme 14).  Shi obtained impressive results over a 
range of alkene substrates with enantioselectivities of >95% achieved.  
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Scheme 14 Epoxidation of an alkene using the Shi ketone 
 
 
1.1.4 Reduction of Carbonyl Compounds 
 
To date, asymmetric hydrogenation, hydrosilylation and borane reductions are the most 
widely used methods for reducing carbonyl compounds.  In industry, hydrogenation is the 
most  favoured  method  but  this  is  of  course  not  without  its  problems  and  limitations, 
namely  associated  with  metal  leaching  and  catalyst  regeneration.    Borane  reductions, 
although managing to avoid these problems, have another limitation; cost of the catalyst,   21 
which can be quite high if applying it to a large scale process.  Hydrosilylation however, 
utilises cheap and readily available silane compounds and coupled with a simple chiral 
activator such as proline 
18 or derivatives of quinoline, 
19 can produce a very efficient 
reduction protocol.  
 
 
1.1.4.1 Borane reduction 
 
Probably the most widely used protocol for the enantioselective reduction of carbonyl 
compounds is the oxazaborolidine-catalysed borane reduction developed by Corey et al.
 20 
This system utilised the proline-derived bicyclic compound 56. 
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The reduction of acetophenone (scheme 15) with BH3.THF (100 mol%), catalysed with x 
(10 mol%), proceeds smoothly in excellent yield and enantioselectivity (97%).  This high 
level of enantioselectivity was also achieved in a wide range of other ketone substrates 
(scheme 15). 
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Scheme 15 Acetophenone reduction mediated by catalyst 56 as well as results for other 
substrate reductions 
   22 
The oxaborolidine catalyst 56 is a key example of a bifunctional catalyst, where the ketone 
and the borane are simultaneously bound to the boron (Lewis-acidic site) and the nitrogen 
(Lewis-basic site).  This results in a complex which allows hydride transfer to the carbonyl 
to be easily achievable. (scheme 16)   
 
O
O
B N
Ph
Ph
H2B
H
O
O
B N
Ph
Ph
BH2 H
intra-complex
hydride shift
63 64
 
Scheme 16 Illustration of how catalyst x acts as a bifunctional catalyst 
 
 
1.1.4.2 Hydrosilylation 
 
Hydrosilylation could be described as the addition reaction of silicon hydrides to multiple 
bonds  such  as  C=C,  C=N  or  C=O.
  21  For  this  reaction  to  work  the  silane,  such  as 
trichlorosilane, would have to be activated.  This could be achieved by using a Lewis base 
such as DMF.  However, as an alternative to this the nucleophilic activator itself could act 
as a chiral inducer.  Hosomi et al 
22 showed that by using a chiral base as the activator, 
hydrosilylation, with trialkoxysilanes, of simple aromatic ketones such as acetophenone 
could be effected in excellent yield and with enantioselectivities of up to 77%.  This was 
achieved by the use of the lithium salts of diolates or amino alcohols (sheme 17).  
O OH HSi(OR)3, Cat 65 or 66
THF, 0oC
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Scheme 17 Asymmetric reduction of ketones using Si(OMe)3 activated by chiral diolates 
or amino alcohols 
 
Since then, a plethora of organocatalytic routes to asymmetric ketone reduction has been 
published within scientific journals.  Very recently Malkov-Kocovsky et al 
19 reported the 
use of isoquinoline derived organocatalysts 67 for the trichlorosilane mediated reduction 
of a series of ketones (figure 3).  As a result, enantioselectivities of 94% ee have been 
achieved, which is by far the best results obtained for the metal-free hydrosilylation of   23 
ketones to date.  With catalyst loadings also as low as 10 mol%, it is also a highly efficient 
protocol too. 
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Figure 3 Reductions of ketones catalysed by catalyst 67 
 
The mechanism proposed for this system is shown in figure 4 below. 
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Figure 4 Proposed mechanism of hydrosilylation 
 
1.1.5 Conclusion 
 
Although organocatalysis is still in its infancy when comparing it to its metal-mediated 
counterparts, it continues to be one of the most dynamic and expanding areas of organic 
chemistry.  New methods appear almost daily in the literature that hope to compete and 
better the equivalent metal-based process.  Although there will always be a need for metal-
mediated catalysis, the pursuit of purely “green” chemistry will no doubt be an ongoing 
one. 
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1.2 Introduction to Asymmetric Catalysis 
 
 
Asymmetric catalysis could be described as the process by which an achiral substrate is 
converted into a chiral product with a preference for one of the enantiomers.  This of 
course is promoted by the use of a chiral catalyst.  These catalysts can range from simple 
organic compounds such as proline 31 to large and elaborate metal-based catalysts such as 
metalloporphyrin complexes 74. 
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The demand for chiral compounds and increasingly those of a single enantiomer has risen 
sharply  over  the  last  few  years.    This  has  been  driven  mainly  by  the  pharmaceutical 
industry since around two thirds of all prescription drugs are chiral, with the vast majority 
being of a single enantiomer. 
23 Classically, chiral compounds were produced by either 
transforming chemically, compounds from  nature‟s „chiral  pool‟ or by  resolution  of  a 
racemic mixture of enantiomers.  These of course suffer limitations in that resolution will 
only yield a maximum of 50% of the required enantiomer and you would also require a 
stoichiometric amount of substrate from the „chiral pool‟ to work with, which of course is 
not always practical or possible.. 
 
In nature, enzymes carry out asymmetric catalysis smoothly and efficiently and the task of 
synthetic  chemists  to  compete  with  nature  is  a  truly  daunting  one.    Today  there  is  a 
multitude  of  different  methods  for  asymmetric  catalysis  spanning  across  all  kinds  of 
synthetic routes and transformations at the disposal of chemists.  The ability to produce 
chiral compounds from simple building blocks, facilitated by a small amount of chiral 
catalyst makes asymmetric catalysis a very powerful tool in organic chemistry. 
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This chapter will try and describe the different reactions that can be carried out in this 
fashion and show the range of different catalysts that can be used. 
 
1.2.1 Asymmetric Hydrogenation 
 
Despite  being  very  simple,  dihydrogen  is  one  of  the  most  significant  and  important 
molecules  in  chemistry.    On  its  own,  dihydrogen  is  very  stable  and  won‟t  react  with 
organic compounds, however, when it is activated by transition metals or their complexes 
then a whole host of reactions can be carried out.   
 
In the early 1970‟s, Knowles  et al 
24 at the Monsanto  Industrial Chemicals Company 
showed that rhodium complexed with chiral phosphine ligands were able to catalyse the 
hydrogenation of a range of alkenes with varying degrees of enantioselectivity.  Using the 
crystalline catalyst 75, the hydrogenation of alkene 76 was achieved in 88% optical purity 
(scheme 18).  This was one of the first examples of a synthetic system that could achieve 
enantioselectivities approaching 100%.  This work earned Knowles a share of the 2001 
Nobel Prize for chemistry (along with Noyori and Sharpless).   
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Scheme 18 Rh-catalysed asymmetric hydrogenation. 
 
The  work  of  Knowles  was  based  upon  the  non-asymmetric  hydrogenation  of  alkenes 
developed by Wilkinson et al. 
25 The mechanism of this process could be visualised in a 
cyclic manner, incorporating 3 main components: dissociation (of a triphenylphosphine 
ligand 78 - 79), oxidative addition (of H2 to the metal 82 - 83) and reductive elimination 
(of the alkane product 84), shown in scheme 19 below. 
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Scheme 19 Wilkinson catalyst mediated hydrogenation of alkenes 
 
Knowing this process allowed Knowles to deduce that incorporating a chiral ligand onto 
the metal would furnish a chiral product.  Knowles‟s process was also commercialised to 
produce  the  anti-Parkinson  drug  L-DOPA  85,  followed  by  the  development  of  other 
syntheses to produce enantio-enriched compounds. 
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Having a suitable combination of both metal and chiral ligand is the key to preparing a 
highly effective catalyst for asymmetric hydrogenation.  The development of chiral C2-
symmetric diphosphine ligands such as BINAP (86), CHIRAPHOS (87), DIOP (88) and 
DuPHOS (89) presented a great advancement in this area.   
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Achieving enantioselectivities of up to 100% with Rhodium complexes (with BINAP) 
26, 
the hydrogenation of functionalised enamides (scheme 20) is still one of the most efficient 
and popular way of synthesising chiral amino acids.   27 
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Scheme  20  Hydrogenation  of  functionalised  enamide  catalysed  by  (S)-BINAP-Rh 
complex 86. 
 
 
1.2.2 Asymmetric Dihydroxylation 
 
This process is used for the enantioselective synthesis of 1, 2-diols from prochiral alkenes 
(scheme 21).   
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Scheme 21 General reaction scheme for the asymmetric dihydroxylation 
 
This reaction has been championed by Sharpless since the early 1980s 
27 where he used a 
stoichiometric amount of osmium tetroxide and reacted it with an alkene in pyridine.  This 
was then followed by a reductive hydrolysis with Lithium aluminium hydride (LAH) to 
furnish the diol.  However, Sharpless was able to make this process catalytic by combining 
it with the Upjohn N-oxide based catalytic process.
28 By using N-methylmorpholine-N-
oxide (NMO) as the cooxidant, (E)-stilbene, 94 could be dihydroxylated using catalytic 
amounts  of  OsO4  and  a  chiral  auxiliary  (DHQD-CBL  95)  in  80%  yield  and  88%  ee 
(scheme 22). 
29   28 
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Scheme 22 Catalytic asymmetric dihydroxylation of (E)-stilbene 
 
The  asymmetric  dihydroxylation  (AD)  has  undergone  major  developments  since  then.  
One of the most significant has been the introduction of the AD mixes.  Since terminal, 
1,1-disubstituted and trans-substituted olefins could be deemed as „standard‟ substrates for 
AD, then as such they would each require similar reaction conditions.   This made it 
possible to premix all the reagents required (OsO2(OH)4, which is a non-volatile source of 
OsO4, K2CO3, K3Fe(CN)6, which is used to oxidise the osmate(VI) species and release 
OsO4 and either (DHQD)2PHAL 97 (for ) or (DHQ)2PHAL 98 (for  ) as the chiral 
ligand) for convenience.
30 
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The  AD  mixes  could  then  be  employed  to  effect  dihydroxylation  and  give  the  added 
benefit  of  being  able  to  predict  which  isomer  is  formed  (ie  if  AD  mix-gives  the R 
isomer, then AD mix- will give the S isomer and vice versa).  A simple illustration has 
been  designed  to  show  the  rationale  for  enantiofacial  selectivity  in  the  AD  reaction. 
(Figure 5) 
   29 
 
Figure 5 Rationale for enantiofacial selectivity 
30 
 
This shows that attack can either occur from the  (in the case of DHQ) or  (in the case 
of DHQD) face.  The NW and SE areas present steric barriers whereas, the NE area is 
open to substrates of moderate size and the SW area can accommodate larger substituents. 
A wide range of olefins can be dihydroxylated using this protocol with enantioselectivities 
of >99% achieved.  The convenience of this protocol along with being able to predict and 
indeed select which isomer is formed makes this a very powerful and attractive tool for 
synthetic chemists. 
 
1.2.3 Asymmetric Aldol reactions 
 
In organic synthesis, the Aldol reaction is one of the most important organic reactions 
since  it  is  carbon-carbon  bond-forming,  which  can  furnish  highly  functionalised 
compounds.  The asymmetric Aldol reaction has the added benefit of producing two chiral 
centres.  The general reaction scheme is shown below (scheme 23). 
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Scheme 23 General base catalysed Aldol reaction 
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Evans  et  al 
32  synthesised  and  studied  Cu(II)  complexes  prepared  from  bisoxazoline 
ligands 101.  He used the ligand complexes in various Aldol addition reactions including 
methyl pyruvate (scheme 24) and benzyloxyacetaldehyde. 
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Scheme 24 Asymmetric Aldol addition of methyl pyruvate with silyl enol ether 
 
The addition went smoothly furnishing the acetophenone adduct in 99% ee using only 10 
mol% of ligand complex.   
 
Denmark  et  al 
33  described  a  process  that  uses  trichlorosilyl  enolates  105  as  the 
nucleophilic components in the asymmetric Aldol addition reaction.  Although these silyl 
enolates are sufficiently reactive to react with aldehydes, he noted that the addition could 
be accelerated in the presence of a Lewis basic chiral phosphoramide 106. 
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Over a range of aldehydes, high levels of enantioselectivity was observed (figure 6). 
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Figure 6 Substrates used in the Aldol addition with 105 in the presence of 106. 
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The proposed mechanism for the transformation of 107 into the -hydroxy ketone 111, 
utilising the phosphoramide catalyst 106 and the silyl enolate 105 is shown in scheme x. 
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Scheme 25 Proposed mechanism for the transformation of 107 into the -hydroxy ketone 
111. 
 
Yamamoto  et  al 
34  showed  that  the  chiral  acyloxyborane  complex  112  was  a  superb 
catalyst for the asymmetric Mukaiyama condensation of simple silyl enol ethers. 
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Using  this  protocol,  the  formation  of  the syn-aldol  adduct  is  preferential  and  in  high 
enantioselectivity.  The general scheme is shown below (scheme 26).  This system is not 
limited only to simple silyl enol ethers but can be extended to ketene silyl acetals also, 
again with high enantioselectivities observed (>97% ee) (scheme 26). 
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Scheme 26 Asymmetric Aldol reaction catalysed by complex 112. 
 
1.2.4 Conclusion 
 
From the few examples reported herein, it is clear to see the advances that have occurred 
within the field of asymmetric catalysis.  The use of metal-derived catalysts to facilitate 
such processes as hydrogenation and Aldol addition, gives the organic chemist access to 
important and enantiomerically-enriched compounds.  Although metal-mediated processes 
are  plagued  by  high  cost  catalysts  and  metal  leaching,  there  will  surely  always  be  a 
requirement for such protocols. 
 
 
1.3 Introduction to imine reduction 
 
From the literature, it is apparent that there are numerous ways in which imines can be 
reduced  into  chiral  amines.    These  methods  can  range  from  hydrogenation  to 
hydrosilylation and from metal-mediated to organo-catalyst mediated reductions. 
 
1.3.1 Hydrosilylation 
 
Hydrosilylation  is  described  as  a  process  by  which  Si-H  element  is  added  across  an 
unsaturated double bond (C=N in this case) 
1. 
 
Lipshutz  et  al 
35  recently  reported  the  use  of  TMDS
#  with  PMHS 
(polymethylhydrogensiloxane),  at  room  temperature,  in  the  highly  enantioselective 
                                                 
# tetramethyl disiloxane   33 
hydrosilylation  of  a  range  of  aromatic  imines.    In  the  presence  of  (R)-(-)-DTBM-
SEGPHOS  117,  N-phosphonyl  imines  118  were  reported  to  be  reduced  in  almost 
quantitative yields with enantioselectivities peaking at >99% ee (scheme 27)  
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Scheme 27 N-phosphonyl imine reduction with 117 
             
The use of MeOH as an additive, in the presence of NaOMe, drove the reaction almost to 
completion.  Switching from CuH to TMDS, with 1% CuCl as the catalyst had a marked 
effect on the selectivity: >99% ee with TMDS compared with 40% ee with CuH.  One 
final observation noted was that when 2-3.3 equivalents of 
tBuOH was added in place of 
MeOH,  the  rate  of  reaction  was  enhanced,  whilst  still  maintaining  the  high  levels  of 
enantioselectivity.  This has proved to be an effective, cost efficient and environmentally 
sound  (since toluene is  the solvent  of  choice)  method of reducing imines in  a  highly 
enantioselective manner.  A suggested transition state for the catalytic cycle is outlined 
below in figure 7. 
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Figure 7 Suggested transition state for the interaction of (R)-(-)-DTBM-SEGPHOS 117 
with the active Cu catalyst and imine 118. 
 
Buchwald et al 
36 discovered a method by which a range of imines could be reduced in 
excellent  enantioselectivity  (>99%  ee).    He  utilised  a  titanium  catalyst  120  and  when 
treated with phenylsilane (PhSiH3) at room temperature, in some cases, the imines could 
be reduced completely  within 12 hours, in high selectivity  (97%  ee as  in  the case of 
reduction of 121). 
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However, it was observed that this level of enantioselectivity was extremely dependant on 
the  N-substituent  of  the  imine  since  it  was  postulated  that  the  nitrogen  would  infact 
coordinate to the Ti.  When the N-substituent was switched from methyl 121 to benzyl 
122,  and  reaction  conditions  kept  the  same,  it  was  noted  that  not  only  did  the 
enantioselectivity drop significantly (<47% ee), but the conversion halved.  This would 
suggest that coordination to the Ti was restricted due to steric factors.  Furthermore, if any 
reaction was to take place at all then the catalyst loading had to be increased 10-fold.  The   35 
silane used was then altered.  He attempted the reduction of 122 again, only this time 
using PMHS
* as the hydride source, but observed similar disappointing results. 
 
The use of nucleophilic catalysts in  organic chemistry to  transform intermediates  into 
more reactive species was utilised in an attempt to make the Ti-amido intermediates more 
reactive.  This would allow the system to be more widely applicable to a wider range of 
imines.  A small range of such nucleophilic catalysts was tested alongside PMHS and the 
titanium ligand 120 on the reduction of 123. 
 
N
123  
From his studies, it was noted that bulky nucleophiles such as 
tbutylamine and secondary 
amines  such  as  pyrrolidine  were  ineffective  as  nucleophilic  catalysts.    Isobutylamine 
proved to be best: furnishing the reduction of 123 with >92% ee with 100% conversion.  
This reaction was also complete in less than 2 hours at 60
oC.  It should be pointed out that 
loading of 120 was only 1%. 
 
It would therefore appear that this is a protocol that benefits from high selectivity and low 
reaction times.  The use of PMHS is beneficial here in that it is a cheap reagent.  The use 
of 120 however, provides problems due to the high cost of metal-based reagents and also 
the environmental impacts associated with metals. 
 
Ireland et al 
37 reported the use of PMHS in the reduction of imines.  As with the research 
of Buchwald 
36, Ireland opted to concentrate the asymmetric tests on imine 122, with the 
general reduction scheme shown below (scheme 28). 
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Scheme 28 General reduction protocol 
 
                                                 
* Polymethylhydrosiloxane   36 
It could be postulated that coordination of the chiral catalyst to the imine, through the 
metal would block one diastereotopic face and thus result in hydride delivery from one 
face only.  This is shown below (figure 8). 
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Figure 8 Propsed mechanism for the involvement of the chiral catalyst and metal in the 
hydride delivery 
 
Varieties of metal-based catalysts, as well as a variety of chiral ligands were screened.  
Without the use of a chiral ligand, it was observed that the catalyst Zn(OTf)2 could be used 
in only 2 mol% whilst still allowing good conversion.  In contrast, the other catalysts ( 
Sn(OTf)2 , In(OTf)3 , Cd(CHB)2 ) all required 10 mol% loading to achieve comparable 
conversions.  The introduction of a chiral ligand (figure 9) did however, allow the catalyst 
loading to be reduced to 2 mol% across the board. 
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Figure 9 Range of chiral catalysts used 
 
On reduction of 123 using 2 mol% of 128, PMHS and Sn(OTf)2, conversion was high but 
enantioselectivity was low (<40%).  With such a low value for enantioselectivity, Ireland 
modified 128 slightly to produce 129.  Using this 3,3‟-disubstituted binapthol and entering 
it into the same reaction conditions as previously used, the conversion remained high, but   37 
most  importantly,  the  selectivity  rose  to  60%  ee.    Although  benefiting  from  high 
conversion rates, this system can only afford moderate selectivity. 
 
The use of metals in this system obviously isn‟t ideal, however, their system does show 
great resilience in that the reactions can be carried out in air without detriment to the 
results. 
 
1.3.2 Oxazaborolidine/borane-mediated reductions 
 
Nakagawa  and  co-workers 
38,  as  part  of  a  drive  to  produce  biologically  important 
alkaloids, turned to reducing imines using new chiral borane reagents.  Dialkoxyborane 
130  was  developed  and  the  reduction  of  a  range  of  -carbolines  (131a-d)  attempted 
(scheme 29). 
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Scheme 29 Reduction of 131a-d with 130 
 
With the reaction carried out at –78
oC in THF, reduction of 131a-c all occurred within 10 
minutes with excellent conversion (98-100%).  Enantioselectivities were low however, 
with 131a-c obtaining 42, 23 and 23% ee respectively.  The reduction of 131d took 7.5 
hours  to  complete  but  again  achieved  high  conversion  (96%).    However,  as  with  the 
others, low selectivity was observed (27% ee).  These particular imines were selected not 
only due to their stability, but also because of their potential in the synthesis of indole 
alkaloids.   
 
With these results at hand, work proceeded to synthesise and reduce a series of aromatic 
and alkyl ketimines still using catalyst 130.  However, when an activator (MgBr2.OEt2) 
was added to the reaction mixture, a marked rise in the enantioselectivity was observed.  
Ketimine 133 (R
1 Et, R
2 Ph, R
3 Ph) was reduced to afford 134 in 73% ee whilst again   38 
retaining high conversion.  Over a range of imines, conversions remained high and the 
selectivities varied from 65-73% ee (scheme 30). 
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Scheme 30 Imine reduction catalysed with 130 
 
The  results  obtained  show  excellent  potential.    With  a  better  understanding  of  the 
mechanism  of  action,  the  system  could  be  developed  to  produce  higher 
enantioselectivities. 
 
The use of chiral oxazaborolidines, especially Corey‟s (S)-methyl-CBS-oxazaborolidine 
135, has found a wide range of applications in relation to ketone reduction.  However, 
little investigation has been carried out on their potential utility in imine reductions. 
 
Field et al 
39 had cause to investigate this potential further and began by reducing imine 57 
with a reducing agent (borane-THF or catecholborane) in the presence of 135 (scheme 31) 
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Scheme 31 Ketimine reduction catalysed by 135 
       
He  found  that  when  borane-THF  was  used,  the  reduction  furnished  58  with  decent 
conversion  (69%)  and  high  selectivity  (87%  ee).    When  catecholborane  was  used, 
conversion increased to 98% whereas the selectivity dropped to 47% ee.  The uncatalysed 
reactions however, were over in <10 minutes, and conversion in both cases were above 
90%.  This, as a result, poses a problem for asymmetric reductions since the catalysed 
reaction would have to be significantly faster than the competing background reaction 
giving racemic product. 
   39 
It was noted the absolute configuration of 58 changed when the reducing agents were 
changed: R for borane-THF (see complex 136) and S for catecholborane (see complex 
137).    They  suggested  that  this  was  apparent  due  to  steric  effects,  and  the  following 
transition states (figure 10) were proposed 
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Figure 10 Proposed transition states 
 
From  the  models  above,  it  can  be  seen  that  if  either  were  to  adopt  the  opposite 
conformations,  then  the  steric  clashes  between  the  aryl  groups  would  prevent  the 
reductions  taking  place.  This  system  shows  the  benefits  of  not  only  obtaining  high 
selectivity, but chiral secondary amines can be produced in a predictable configuration.  
The high costs of the borane reagents are the only limiting factor to this system. 
 
1.3.3 Hydrogen-transfer reductions 
 
One of the most common methods of preparing amines is the metal-catalysed reductive 
amination of carbonyl compounds with hydrogen as the reducing agent.  
40   Kadyrov et al 
recently developed a highly selective catalytic system for the reductive amination of -
keto acids 
41.  This involved reacting a -keto acid in methanolic ammonia (NH3/MeOH) 
at  60
oC  in  the  presence  of  a  rhodium  catalyst.    This  was  shown  to  furnish  the 
corresponding amine smoothly (scheme 32).   40 
O
COOH
Ph
O
HN
COOH
Ph NH3/MeOH, H2
[Rh(cod)2]BF4
BnNH2
138 139 140
 
Scheme 32 Reaction of an a-keto acid in the presence of a Rh catalyst 
 
Based  on  this  result,  they  attempted  asymmetric  reductive  amination,  using  a  chiral 
catalyst 
42.  Under Leuckart-Wallach reaction conditions
#, they used ammonium formate 
as  the  hydrogen  source,  which  was  shown  to  work  best  with  a  range  of  metal-based 
catalysts (scheme 33). 
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Scheme 33 Reductive amination under Leuckart-Wallach conditions 
 
The mechanism for this process is suggested below (scheme 34). 
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Scheme 34 Mechanism for reduction under Leuckart-Wallach conditions. 
 
Initial tests showed that the catalysts [((S)-binap)RuCl2] and [(R)-tol-binap)RuCl2] proved 
to  be  most  effective:  both  affording  ee‟s  >90%  for  the  reductive  amination  of  2-
acetylnapthalene.  Coordination of the metal to the nitrogen of the imine intermediate 
would shield one face from attack, leaving the other face open for hydride transfer.  Or 
indeed, coordination to the imine nitrogen and formic acid may align the substrates up in 
                                                 
# The reduction of carbonyl compounds with formic acid or formamide   41 
such a way that hydride transfer will occur preferentially to one face of the imine.  This 
would of course be selective for the catalyst used (ie R or S). 
 
Further tests identified [(R)-tol-binap)RuCl2] to be the champion catalyst.  When reacted 
with ammonium formate in NH3/MeOH at 85
oC, a series of 12 substrates were reduced in 
high enantiomeric excesses >91%.  Kadyrov and co-workers have developed an admirable 
system for the synthesis of primary amines.  It has also shown high levels of asymmetric 
induction for aromatic ketones. 
 
1.3.4 Hydrogenation 
 
The enantioselective hydrogenation of olefins and ketones using phosphorous ligands in 
catalytic systems is well documented.  However, only a handful of highly selective imine 
hydrogenations have been reported.  Spindler 
43 reported the reduction of imine 125 with 
Rh/bdppsulf occurred with high conversion and optical purity (94% ee). 
 
Claver et al 
44 have recently reported the use of iridium complexes as effective catalysts 
for the selective hydrogenation of imines.  Up until now, iridium-diphosphines were the 
most effective and commonly used systems for hydrogenation, but little was known about 
the use of diphosphite or diphosphonites as chelating phosphorus ligands. 
 
Reetz 
45  and  Dieguez 
46  had  recently  reported  the  potential  of  diphosphite  and 
diphosphonite ligands.   A range of alkyl  and aromatic olefins  had been hydrogenated 
using different rhodium diphosphite ligands with enantioselectivities >98% ee.  Based on 
these  initial  findings,  it  was  decided  to  apply  xylose-based  diphosphonite  149  and 
diphosphite 150, 151 ligands in the hydrogenation of imine 57. 
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Instead of using rhodium, the use iridium was employed and the corresponding metal 
complexes of 149 and 152 synthesised. 
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Initial hydrogenations of 57 showed promise.  Using complex 152, corresponding amines 
of 57 could be produced with moderate selectivities of ~57% ee.  The pressures required 
for this transformation remained relatively low at 10 bar.  The same reaction was again 
tried, only this time adding Bu4NI as an additive to observe if it had any effect on the 
enantioselectivity.  Although conversion was high (96%), the additives had a detrimental 
effect on the enantiomeric excess: lowering it to 15% ee. 
 
On testing the same hydrogenation using the Ir-complexes of 150 and 151, without the use 
of the additive, almost racemic amines were obtained.  However, on addition of Bu4NI or 
simply I2, selectivity peaked at >46% ee. 
 
These  results  have  revealed  that  diphosphite  and  diphosphonite  ligands  can  induce 
moderate selectivity for the hydrogenation of imines.  It has also been shown that the 
enantioselectivity obtained is strongly dependant on the structure of the ligand as well on 
the effect of additives. 
 
1.3.5 Other Reactions 
 
When developing a new system for asymmetric reductions, it is important to obtain the 
racemic product from the reduction in order to ascertain whether or not the asymmetric 
results are indeed valid.  To do this, reducing agents such as NaBH4 or LiAlH4 can be 
used.  However, if the substrate being reduced already contains a chiral centre close to the 
double bond, then the use of NaBH4 can afford highly diastereoselective results.   43 
Weissensteiner et al 
47 utilised this concept when designing new ferrocene-based ligands.  
They looked at designing a simple and selective synthesis of amine 153. 
 
N
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The resolution of this amine was very time consuming, so the ultimate aim here was to 
find an easier way to make it.  Starting from 154, it only took two easy steps to obtain the 
correct framework and in the correct configuration (scheme 35). 
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Scheme 35 Synthesis of 153.  
 
The key step in this synthesis was the diastereoselective NaBH4 reduction of imine 155.  
Due  to  the  highly  selective  diastereofacial  reduction,  156  was  furnished  as  a  single 
diastereomer and in almost quantitative yield.  Three more simple steps were performed to 
afford 153 in an overall yield of 54% with optical purity of >98%ee.  He postulated that 
because imine 155 was syn, then the NaBH4 reduction could be rationalised by a hydride 
attack at the C=N bond carbon on the Si face 157.  This step then determined the absolute 
configuration of the final product 153. 
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However, (S)-(-)-Np-EA (naphthalene ethylamine) is a rather costly chiral auxiliary, so it 
was decided to try using the much cheaper (S)-(-)-PEA (phenyl ethylamine) instead.  It 
was discovered that use of this auxiliary furnished 151 in 55% yield with an optical purity 
of >98%.  It has been shown that the synthesis of 153, which used to be costly, can now be 
achieved, without detriment to the purity or yield, at a lower cost. 
 
 
1.4 Introduction to - interactions 
 
It  has  been  recently  shown  that  -interactions  can  have  a  distinct  impact  on  the 
reactivity and enantioselectivity of organocatalytic reactions
 48.
  The term -shielding is 
used to describe the way that one face of an unsaturated moiety is shielded from attack 
from  an  incoming  species  by  an  interaction  of  an  aromatic  group  and  is  described 
thoroughly in the 2001 review by Jones. 
49 For example, the -face of an unsaturated 
compound could be shielded from attack, thus allowing attack to occur exclusively on the 
-face 158. 
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This interaction can take two forms; it can be of steric origin or of electronic origin.  The 
steric origin is how is sounds, merely blocking the approach to the shielded face.  The 
electronic origin however, describes an established stabilising interaction between the two 
components.    However,  when  an  intramolecular  distance  of  3-4  Å  between  the  two 
components is observed, then these two forms of interaction are collectively referred to as 
-stacking, regardless of whether the origin of it is steric or electronic.   
 
-stacking refers to the interaction of the -cloud of the unsaturated moiety with the aryl 
component.  This can take the form of a face-to-face or edge-to-face 159 relationship 
with the aryl component.  
50 
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There  are  some  examples  of  asymmetric  transformations  that  rely  on  interactions 
cited in the literature, as well as examples of yet un-addressed possibilities that may exist 
for the said systems.  To try and quantify what interactions are and how they work in 
real  terms,  several  asymmetric  transformations,  namely  cycloadditions,  conjugate 
additions,  alkylations  and    interactions  related  to  artificial  receptors  will  be 
described herein. 
 
1.4.1 Cycloadditions 
 
In recent years, nitrone-olefin [3+2] cycloadditions, applied in the synthesis of nitrogen-
containing natural products have been proving very fashionable.  The reason behind this 
popularity is its ability to add both amino and hydroxyl functionalities to a molecule in 
chorus as well as lengthening the carbon-chain length by sometimes more than two units: 
a process fundamentally difficult to achieve. 
 
Saito et al 
51 utilised the concept of facial shielding when designing chiral nitrones for this 
process.  He discovered that when nitrone 160 underwent a [3+2] cycloadditions with 
DMAD (dimethyl acetylendicarboxylate), adduct 161 was formed exclusively (scheme 
36). 
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Scheme 36 [3+2] cycloaddition 
 
It  was  rationalised  this  result  on  the  basis  that  one  face  of  the  [C=N]  dipole  was 
exclusively shielded, most likely caused by -interactions between the PMB moiety and 
Bn group 162.   46 
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It was proven that this interaction was achievable by showing that the Z-isomer was in fact 
the exclusive isomer by conducting nOe studies.  A nOe of 7.2% was observed on the 
benzylic protons when the azomethine proton was irradiated.  A coupling constant of 3.2 
Hz  between  the  two  protons  on  the  vicinal  protected  diol  unit  also  supported  this 
conformation.  160 [R = Bn] was then reacted with -butenolide 163 to afford adduct 164 
in 89% de (scheme 37). 
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Scheme 37 [3+2] cycloaddition. 
 
From this work, the strength of  interactions in asymmetric synthesis has been shown.  
To produce 3 stereogenic centres in a controlled and predictable fashion is no easy feat, 
and as a result Saito has turned his attention to the problem of how to discriminate the -
[C=C]-face of the olefin.  Work on this area continues. 
 
Jacobsen et al 
52 recently discovered that a C2-symmetric 1,2-diimine could be an effective 
ligand for the Cu (I)- catalysed aziridination and cycloproponation reactions  (Scheme 
38). 
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Scheme 38 Aziridination 
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The diimine complex 169 
53 was then synthesized and coordinated to styrene 170 and Cu 
to afford complex 171. 
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He then successfully managed to crystallise complex 171 and as a result, unearthed some 
unanticipated characteristics.  Simultaneous face-to-face and edge-to-face  interactions 
were  shown  to  be  occurring  within  the  complex  between  the  substrate  and  the  chiral 
ligand.  This is more clearly shown below 172. 
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This type of simultaneous interaction has already been proven to play a crucial role in the 
enantioselective outcome of the Sharpless asymmetric dihydroxylation reaction
 54.  
 
It has been revealed that attractive edge-to-face and face-to-face  interactions can play 
an influential role in the enantiofacial selectivity in the binding of prochiral substrates to 
this class of chiral catalyst.  He has shown that complex  171 can be formed with an 
enantiofacial selectivity of >98:2 (or >96% de). 
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1.4.2 Conjugate Additions 
 
The synthesis of synthetically useful dihydropyridones by addition of Grignard reagents to 
acylpyridinium salts can pave the way to synthesis of alkaloids in an enantioselective 
manner.  Comins et al 
55 have recently been working on just that.  By exploring different 
cyclohexyl-based chiral auxiliaries of the 8-phenylmenthol type, he found that Grignard 
addition to an acylpyridinium ion could give access to a dihydropyridones in up to 95% 
de.  It was found that the CPC auxiliary 172 (cyclohexyl based auxiliary of the 8-
phenylmenthol) type was best and when coupled to a pyridinium ion of type 173, 175 
could be formed in >95% de after alkyl addition, with the dihydropyridones unlocked after 
hydrolysis (scheme 39). 
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Scheme 39 Conjugate addition of PhMgBr to 173.            
   
This high selectivity was most probably explained by  interactions.  The overlap of the 
phenyl group with the pyridinium ion could be reasonably assumed, thus resulting in the 
top face becoming shielded and only lower face attack occurring 174. 
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This particular auxiliary proved most effective but the contribution of the 
iPr group is not 
easily explained, but may influence rotamer populations and thus provide the optimum 
  overlap.  This  work  carried  out  by  Comins  further  shows  the  effect  that   
interactions  have  on  asymmetric  synthesis  when  producing  enantioselectively, 
synthetically useful compounds.   49 
1.4.3 Alkylations 
 
Winterfeldt et al 
56 utilised the concept of -shielding with a diastereoselective alkylation 
in  part of the synthesis of Clavularin  A.  The enolate  176 of  177 underwent  a  clean 
alkylation with the allylic iodide 178 to give selectively the cis-product 179 (scheme 40). 
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Scheme 40 Alkylation of 177 with 178. 
 
This observation was rationalised by predicting that there was a remote interaction 
with the aryl group shielding the -face of the [C=C] of the enolate.  This resulted in the  
or syn-product being formed exclusively.  The role of the p-methoxy group, if any, could 
not be ascertained with any great clarity. 
 
Negrete et al 
57 also studied the stereoselective alkylation of enolates, but in a bid to study 
the influence of intramolecular  interactions, he synthesized the sodium enolates of a 
range of aryl  pyrimidinones including  180.   This was alkylated simply  using methyl 
iodide and the stereochemistry of 181 determined (scheme 41). 
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Scheme 41 Alkylation of aryl pyrimidinone 180 
 
In this case 181 was formed in decent diastereoselectivity with high conversion also.  With 
this result in mind, it was postulated that -stacking (face-to-face) between the two aryl 
groups resulted in the upper face becoming blocked and allowing almost selective attack 
at the lower face (see figure 11).   50 
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Figure 11 Role of arene-arene interactions in selective alkylations 
 
1.4.4 Artificial Receptors 
 
In recent years there has been a growing interest in the development of synthetic receptors 
where diaryl compounds 183 can interact in unexpected ways.  These compounds can 
adopt  -orientated conformations that will allow substrates to interact with receptor 
framework in a manner external 184 or internal 185 to it. 
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Deslongchamps and co-workers 
58 developed an example of a synthetic receptor 185.  The 
compound  was  designed  to  specifically  probe  the  stacking  interactions  in  Adenine: 
Thymine base pair mimics. 
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When the receptor was reacted with 9-butyladenine 186, NMR analysis of the complex 
showed there to be evidence of both Watson-Crick 187 and Hoogsteen 188 complexes, so 
the participation of -stacking interactions were confirmed. 
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1.4.5 Conclusion  
 
The concepts of  interactions (-shielding and -stacking) continue to be used to 
explain the outcome of numerous regio- and stereochemical processes.  As the concept of 
 interactions is still in its infancy, evidence reported herein would suggest that with a 
proper and full understanding, it may be possible to unlock and harness its full potential. 
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Chapter 2: Results and Discussion 
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2. Results and Discussion 
 
 
2.1 Introduction 
 
To date, the asymmetric reduction of ketones, both stoichiometric and catalytic is well 
known and well developed.
59  However, the corresponding ketimine reductions have a 
much  more  limited  portfolio  of  protocols  and  applications.
59-61  These  protocols  rely 
heavily  on  transition  metal  catalysis  with  the  most  successful  being  high  pressure 
hydrogenation,
59,60  hydrosilylation
58,60  and  transfer  hydrogenation.
60,42  These  classical 
approaches (Scheme 42), although effective, suffer from the problems of metal leaching 
and  catalyst  regeneration.    The  metal  leaching  can  be  a  considerable  problem  if  the 
protocol is being used in the manufacture of pharmaceuticals and due to the high cost of 
the catalysts, not being able to regenerate them can have significant economic implications 
for users.  So for these reasons, the development of an organocatalytic approach would 
seem to be very attractive. 
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Scheme 42 General scheme for the reduction of ketimines 
 
In  general,  to  develop  a new catalytic protocol involves  a fine balancing act  between 
various factors, such as catalyst structure, loading, solvent and temperature.  Often even an 
insignificant change in any of these factors can result in a very significant change in the 
stereochemical outcome of the reaction and not always for the better.
59,62 There are many 
approaches that can be used to help design a catalyst but one which is gaining strength is 
the chiral relay effect.
63 This is designed to enhance enantioselectivity through structural 
variations by carefully placing a conformationally flexible group in such a way that the 
chiral information from the catalyst can be passed onto the reaction centre.
63 This was 
shown effectively by the Kocovsky-Malkov group.
64  For the Cu(I)-catalysed conjugate 
addition of Et2Zn to ,-enones (Scheme 43) it was shown that the N-methylamino acid-
derived  amidophosphine  ligands  derived  from  N-methylvaline  193  (83%  ee)  were  far 
superior to those derived from proline 194 (7% ee).  This showed that the rigid, cyclic 
framework of proline did not always provide an advantage over the flexible framework of 
valine. 
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Scheme 43 Conjugate addition showing the benefit to using flexible catalysts over rigid 
catalysts 
 
Herein, it will be shown that these principles can be utilised in the area of organocatalysis 
and can be used to affect a powerful protocol for the catalytic asymmetric reduction of 
ketimines to chiral amines. 
 
2.2 Ligand Synthesis and Initial Investigation 
 
Since it is known that Cl3SiH can be activated by Lewis bases such as DMF, MeCN, R3N 
etc, to effect the hydrosilylation of imines we set about designing a chiral Lewis-basic 
ligand, based on N-methylvaline, that could be viewed as a chiral analogue of DMF 195.  
Designing  these  analogues  made  use  of  amino  acids  as  the  chiral  scaffold  with  the 
amino group converted into the formamide moiety 196.  The analogue of DMF would 
then be completed by the inclusion of a chiral moiety in place of one of the methyl groups 
196. 
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R = aliphatic or aromatic 
To increase the scope for the ligand we intended to functionalise the amino acid carboxyl 
into another amide group and thus create the possibility for bidentate coordination using 
either an aliphatic or aromatic amine 197.  With this in mind, the initial synthesis was 
carried  out.    Valine  was  utilised  as  the  starting  amino  acid  due  to  its  low  cost  and 
availability.  It was thought that the -isopropyl group would provide a sterically hindered 
enough group whilst the N-methyl group was thought essential to invoke the chiral relay 
effect. 
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The synthesis was started with the N-methylation of the 
tBOC-protected L-valine 198 with 
MeI in the presence of NaH (Scheme 44), which furnished the 
tBOC protected N-methyl 
valine in almost quantitative yield 199.  This reaction was not trivial however.  Logic 
would  suggest  that  deprotonation  of  the  N-H  should  be  carried  out  first  with  sodium 
hydride, followed by the addition of the methyl iodide.  This however, proved not to be 
the case and in fact, the sodium hydride had to be added portion-wise to a solution of 
amino  acid  and  methyl  iodide  otherwise  the  reaction  would  become  very  sluggish.  
Another problem arising from this protocol was the addition of the hydride which involves 
the  evolution  of  hydrogen  which  required  careful  venting.    In  addition  to  this,  if  the 
hydride was not added portion-wise over a certain time-scale (~1h) then the reaction did 
not work.   
The use of dimethyl sufide as a N-alkylating reagent, in the presence of sodium hydride, 
had literature precedence 
65 however, when the N-methylation of 
tBOC-valine 198 was 
attempted, it was discovered that alkylation had occurred preferentially at the carboxyl 
end.  This method was therefore abandoned in favour of the alkylation with methyl iodide 
which produced tertiary amide 199 in 98% yield.   56 
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Scheme 44 Synthesis of the parent ligand 197a 
 
Amide 100 was then converted into bis-amide 101 using the mixed anhydride method for 
amine  coupling.    The  mixed  anhydride  was  formed  in  situ  from  199  and  methyl 
chloroformate and then reacted with aniline to furnish 200.  Deprotection of the 
tBOC 
group  was  then  carried  out  with  TFA  in  CH2Cl2  to  afford  the  TFA  salt  which  was 
subsequently formylated via a mixed anhydride, generated in situ from formic acid and 
acetic anhydride to furnish the ligand 197a.   
An initial asymmetric reduction was carried out using 102 and a simple acetophenone 
based  imine  189a  (Scheme  45).    The  result  proved  very  promising  giving  the 
corresponding secondary amine 201a in 79% ee.   
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Scheme 45 Initial asymmetric reduction 
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Whilst  the  initial  investigation  was  underway,  Matsumura  et  al 
66  reported  the  same 
reduction catalysed by the L-proline derived formamide (S)-202 with enantioselectivities 
of This provided credence that the flexible nature of the valine skeleton was more 
beneficial than that of the rigid,  cyclic skeleton  of proline.  However,  one interesting 
observation was that although both the valine (197a) and proline (202a, b) ligands were 
the same configuration, (S), the amines generated from the two asymmetric reductions 
were  in  fact  opposite  enantiomers!    This  suggested  that  the  enantiodifferentiating 
mechanisms for valine- and proline-derived ligands are significantly different and would 
require a thorough investigation into the structural effects of both the ligand and substrate.  
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The investigation started with the variation of the amide functionality on the ligand.  This 
was carried out simply by altering the amine used at the coupling stage and as a result a 
series of ligands 197a-e, 203a,b, containing both aromatic and aliphatic moieties were 
realised.  
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The synthesis of this series of ligands was carried out in the same way as described. In one 
case however, the synthesis failed when trying to attach 3,5-bis-(trifluoromethyl)aniline, 
204.  Due to the electron withdrawing nature of the trifluoromethyl groups, the nitrogen is 
far less nucleophilic, therefore pivaloyl chloride was employed here to generate the mixed 
anhydride.  This procedure worked well to furnish the desired amide, but as a consequence   58 
of the more acidic conditions, the 
tBOC group was also removed.  The formylation step 
was then carried out to furnish 197e (Scheme 46).   
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Scheme 46 Synthesis of N-methyl valine-derived ligands. 
 
The remaining valine-derived analogues, 205 and 206 were then synthesised.   
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The trifluoroacetamide 205 was obtained from 200b via deprotection of the 
tBOC group 
followed by acylation with trifluoroacetic anhydride.  The urea derivative 206 was formed 
from 200c by deprotection followed by treatment with phenylisocyanate.   
 
2.3 Asymmetric Reduction 
 
Initial  work  was  carried  out  using  ligand  197a  and  a  range  of  imines  based  on  the 
acetophenone motif 189a-j.  Each reduction was carried out with a catalyst loading of 
10mol% and in the first instance, performed in CH2Cl2.  As mentioned previously, early 
results were promising with the reduction of 189a furnishing the corresponding amine in 
good yield and with 79% ee.  By simply altering the solvent to CHCl3, an increase in yield 
was observed as well as in increase in enantioselectivity to 86% ee.  Lowering the reaction 
temperature to -20
oC also gave a marked rise in enantioselectivity (92% ee) but at the 
detriment to the reaction rate.  Changing the solvent once more to MeCN showed a large 
reduction in both yield and enantioselectivity. 
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Previous work within the Kocovsky-Malkov group had shown the powerful impact that 
arene-arene  interactions  could  have  on  organocatalysis.
67  The  effect  of  changing  the 
solvent  system  seemed  to  substantiate  the  idea  that  non-covalent  interactions  were 
involved in the reduction, since it had been shown that CHCl3 was the solvent that would 
most strongly stabilise arene-arene interactions. 
68 This was further examined by altering 
the structure of the imines and indeed at the same time explore the scope of the reductive 
system.  By comparison of the electron-rich and electron-deficient imines (189b and 189c 
respectively)  it  was  noted  that  the  electronic  effect  on  both  reactivity  and 
enantioselectivity  was  minimal  (table  1).    Removing  the  aromatic  ring  on  the  ketone   60 
portion of the imine (189e) resulted in a marked reduction in enantioselectivity (37% ee) 
(table 1, entry 10) but lowering the reaction temperature to -20
oC increased this to 59% ee 
(see table 1, entry 11).  This would suggest that there is a fast, non-catalytic background 
reaction in play which is suppressed by cooling the reaction.  Inclusion of a 2-naphthyl 
group  (189d)  had  little  effect  on  the  reduction,  with  similar  reactivity  and 
enantioselectivity as shown in the reduction of 189a. 
 
Table 1 Reduction of imines 189a-j with ligand 197a and 203a,b.
a 
entry  imine  cat 
 
solvent  yield 
(%)
b 
amine,  
% ee
c 
(config)
d 
 1  189a  197a  CH2Cl2  68  79 (S)
 
 2  189a  197a  CHCl3  79  86 (S)
 
 3
e  189a  197a  CHCl3  49  92 (S)
 
 4  189a  197a  MeCN
  65  30 (S) 
 5  189a  203a  CH2Cl2  91  55 (R)
f 
 6  189a  203b  CH2Cl2  52  66 (R)
f 
 7  189b  197a  CHCl3
  57  80 (S)
 
 8  189c  197a  CHCl3
  43  87 (S) 
 9  189d  197a  CHCl3
  60  87 (S)
 
10  189e  197a  CHCl3
  80  37 (S) 
11
e  189e  197a  CHCl3
  53  59 (S)
 
12  189f  197a  CHCl3
  96  85 (S)
 
13  189g  197a  CH2Cl2
  36  22 (S)
 
14  189h  197a  CHCl3
  50     <5 
15  189i  197a  CHCl3
  60     <5 
16  189j  197a  CHCl3
  46       8 
aThe reaction was carried out at 0.5 mmol scale with 1.5 equiv of Cl3SiH and 10 mol% of the catalyst at 
room temperature  for 16 h. 
bIsolated  yield. 
cDetermined  by chiral HPLC or GC. 
dEstablished  from the 
optical rotation (measured in CHCl3) by comparison with the literature data (see the Experimental section) 
and/or by HPLC/GC via comparison with authentic samples. 
eThe reaction was carried out at 20 
oC. 
fRef 9 
 
 
The alteration of the N-substituent on the imine had a much more marked effect.  It was 
shown that steric effects must play a part in the reductive mechanism since the p-methoxy 
imine gave high conversion (96%) and high enantioselectivity (85% ee) (table 1, entry 
12), whilst the corresponding o-methoxy isomer was much more sluggish, with both low 
conversion (36%) and low enantioselectivity (22% ee) (table 1, entry 13).  Removal of the 
aromatic substituent altogether (189h, i) or by moving it one carbon further away from the 
nitrogen centre (189j) resulted in poor conversion and almost racemic product (see table 
1, entries 14-16), showing that the N-aryl moiety is essential for chiral induction.   61 
The role of the aromatic functionality of the catalyst was probed using catalysts 197a-b 
and 203a-b (Table 2).  Reduction of imine 189a with the 3,5-dimethoxy catalyst 102b 
proved to be less efficient than the same reduction with 197a, showing that the inclusion 
of  donor  groups  on  the  aryl  ring  was  detrimental.    Reduction  of  189a  with  the  3,5-
bis(trifluoromethyl) catalyst 197e gave a similar result indicating that electronic effects are 
not too important.  Conversely, reduction with the 3,5-dimethyl catalyst 197c actually 
showed an increase in both conversion and enantioselectivity over the reduction with the 
parent formamide 197a, demonstrating the importance of steric factors.  Removing the 
aromatics completely and replacing it with an n-butyl moiety 197d resulted in no reaction 
whatsoever, proving the importance of the aromatic moiety.  The diethylamide 203b as 
expected proved ineffective, further strengthening the premise that the aromatic system is 
vital.  The tertiary amide 203a also showed itself to be ineffective which may indicate that 
hydrogen bonding between the catalyst and imine is an important feature of the transition 
state.   
 
HN HN
O
O
H
O
O
207  
 
Furthermore,  removing  the  N-methyl  group  from  the  formamide,  207,  reduced  the 
efficiency of the catalyst.  This would further strengthen the argument that the N-methyl 
group is vital for the chiral relay.
63 
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Table 2 Reduction of imines 189a, c and f with ligand 197b-e and 203a, b and 207.
a 
entry  imine  cat  solvent  temp 
(
oC) 
yield 
(%)
b 
 amine, 
% ee
c 
(config)
d 
 1  189a  (S)-197b  CHCl3  ambient  81  82 (S) 
 2  189c  (S)-197b  CHCl3  ambient  94  77 (S) 
 3  189f  (S)-197b  CHCl3  ambient  82  79 (S) 
 4  189a  (S)-197c  CHCl3  ambient  70  89 (S)
 
 5
  189a  (S)-197c  CHCl3  –20  94  92 (S)
 
 6  189a  (S)-197d  CHCl3  ambient    0    – 
 7  189c  (S)-197e  CHCl3  ambient  92  69 (S) 
 8  189a  (S)-197e  CHCl3  ambient  88  53 (S) 
 9   189a  (S)-203a  CHCl3  ambient  23    7 (S) 
10  189a  (S)-203b  CHCl3  ambient    0    – 
11  189c  (S)-207  CHCl3  ambient  84  35 (S) 
aThe reaction was carried out at 0.5 mmol scale with 1.5 equiv of Cl3SiH and 10 mol% of the catalyst for 16 
h. 
bIsolated yield. 
cDetermined by chiral HPLC or GC. 
dEstablished from the optical rotation (measured in 
CHCl3) by comparison with the literature data (see the Experimental) and/or by HPLC/GC via comparison 
with authentic samples.  
 
The reductions to this point had been carried out mainly in chlorinated solvents, with 
CHCl3 proving best.  MeCN proved to be ineffective for this protocol suggesting that a 
non-polar solvent  was  important.   Since neither CHCl3 nor CH2Cl2  are  deemed to  be 
environmentally friendly, another non-polar solvent, toluene, was investigated and was 
quickly found to be the solvent of choice.  In fact, the reduction of 189a with catalyst 197c 
in toluene, at room temperature actually matched the same reduction in CHCl3 at –20 
oC 
with catalyst 197a in terms of enantioselectivity but in much better yield.  Since catalyst 
197c appeared to be best, more reductions were carried out in toluene to investigate its 
efficiency (see Table 3). 
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Table 3 Reduction of imines 189a-c, f and k with ligand 197c.
 a 
 
entry  imine  cat  solvent  temp 
(
oC) 
yield 
(%)
b 
 amine, 
% ee
c 
(config)
d 
 1  189a  (S)-197c  Tol  ambient  81  92 (S)
 
 2  189a  (S)-197c  Tol  –20  54  92 (S)
 
 3  189b  (S)-197c  Tol  ambient  86  85 (S)
 
 4  189c  (S)-197c  Tol  ambient  86  89 (S)
 
 5  189c  (S)-197c  Tol  –20  80  89 (S)
 
 6  189f  (S)-197c  Tol  ambient  85  91 (S)
 
 7  189f  (S)-197c  Tol  –20  46  93 (S)
 
 8  189k  (S)-197c  Tol  ambient  90  92 (S)
e 
aThe reaction was carried out at 0.5 mmol scale with 1.5 equiv of Cl3SiH and 10 mol% of the catalyst for 16 
h. 
bIsolated yield. 
cDetermined by chiral HPLC or GC. 
dEstablished from the optical rotation (measured in 
CHCl3) by comparison with the literature data (see the Experimental) and/or by HPLC/GC via comparison 
with authentic samples. 
eConfiguration is assumed to be (S) in analogy with the rest of the series. 
 
With  the  exception  of  the  reduction  of  189f,  which  showed  a  marginal  increase  in 
enantioselectivity, there  was  no further improvement in  carrying out  the reductions  at                
-20
oC (table 3, entry 6-7).   
 
Modification  of  the  amino  acid  side  chain  was  investigated  next.    This  was  achieved 
simply by varying the amino acid used in the catalyst synthesis.  Four differing amino 
acids were chosen as suitably different to valine but not so much that the overall structure 
would change dramatically (in terms of sterics etc).   
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H
208d  
 
The  catalysts  were  synthesised  from  phenylglycine  208a,  phenylalanine  208b,  alanine 
208c and leucine 208d following the same protocol as previously (see scheme 47) 
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(R)-209a, R = Ph, R' = H
(S)-209b, R = PhCH2, R' = H
(S)-209c, R = Me, R' = H
(S)-209d, R = Me2CHCH2, R = H
(R)-210a, R = Ph, R' = Me
(S)-210b, R = PhCH2, R' = Me
(S)-210c, R = Me, R' = Me
(S)-210d, R = Me2CHCH2, R = Me
1. CF3CO2H
2. HCO2H, Ac2O
N OH
O R
BOC
R' N HN
O R
BOC
Me
1. MeOCOCl, Et3N
2. 3,5-Me2C6H3NH2
(R)-211a, R = Ph
(S)-211b, R = PhCH2
(S)-211c, R = Me
(S)-211d, R = Me2CHCH2
* *
N HN
O R
Me
*
O
H
(R)-208a, R = Ph
(S)-208b, R = PhCH2
(S)-208c, R = Me
(S)-208d R = Me2CHCH2  
Scheme 47 Synthesis of alternative N-methyl amino acid catalysts  
 
Reductions of various imines were carried out, catalysed by 208a-d in toluene at room 
temperature (see Table 3.3.4).  The reduction of 103c with the leucine-derived catalyst 
112d showed excellent reactivity (89%) but very low chiral induction (10% ee) (table 4, 
entry 7).  The alanine-derived catalyst 208c showed moderate enantioselectivity (38% ee) 
(table  4,  entry  6)  the  reduction  of  imine  189c  but  interestingly  induced  the  opposite 
enantiomer  of  the  amine  preferentially.  The  phenylalanine-derived  catalyst  208b  also 
showed  low  enantioselectivity  (26%  ee)  (table  4,  entry  4)  but  surprisingly  the 
phenylglycine-derived catalyst 208a gave rise to a completely racemic mixture 
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Table 4 Reduction of imines 189c and f with ligand 205- 206 and 208a-d
a 
entry  imine  cat  solvent  yield 
(%)
b 
amine,  
% ee
c 
(config)
d 
 1
e  189a  (R)-208a
  Tol  84    0
 
 2
e  189c  (R)-208a  Tol
  70    0 
 3
e  189f  (R)-208a  Tol  76    0 
 4  189c  (S)-208b  Tol
  85  26 (S)
 
 5  189f  (S)-208b  Tol  84  49 (S)
 
 6  189c  (S)-208c  Tol
  92  38 (R)
 
 7  189c  (S)-208d  Tol
  89  10 (S) 
 8  189a  (S)-205  CH2Cl2  <10    0 
 9  189c  (S)-206  Tol
  70    0 
a The reaction was carried out at 0.5 mmol scale with 1.5 equiv of Cl3SiH and 10 mol% of the catalyst for 16 
h. 
bIsolated yield. 
cDetermined by chiral HPLC or GC. 
dEstablished from the optical rotation (measured in 
CHCl3) by comparison with the literature data (see the Experimental) and/or by HPLC/GC via comparison 
with authentic samples. 
eNote the (R) configuration of the catalyst. 
 
To probe the importance of the formamide moiety on the catalyst activity, the valine-
derivatives that had the formamide portion replaced by a trifluoroacetamide group 205 and 
a urea group 206 were tested.  The much less Lewis-basic trifluoroacetamide proved to be 
totally inefficient, having no effect on the reduction whatsoever.  The urea derivative did 
however catalyse the reduction but afforded only racemic product.  This gave strength to 
the opinion that the formamide portion is crucial for its catalytic activity. 
 
In terms of efficiency and enantioselective outcome, the 3,5-dimethylphenylamide catalyst 
is undoubtedly the best.  Work carried out within the Kocovsky-Malkov group 
69  at the 
same  time  investigated  the  use  of  two  other  amino  acid  catalyst  derived  from 
cyclohexylglycine 212 and tert-leucine 213, the synthesis of which are shown in scheme 
48.  
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(R)-214a, R = c-hexyl
(S)-214b, R = t-Bu
(R)-215a, R = c-hexyl
(S)-215b, R = t-Bu
(R)-216a, R = c-hexyl
(S)-216b, R = t-Bu
(R)-217a, R = c-hexyl
(S)-217b, R = t-Bu
N OH
O R
Me
H
N O BOC
R O
N OH
O R
CHO
Me
N OH
O R
H
BOC
(CH2O)n, CSA
PhMe, reflux
Et3SiH, TFA
(+)-212, 213
3,5-Me2C6H3NH2
EDCI, HOBt, Et3N
HCO2H, Ac2O
* *
* *
 
 
Scheme 48 Attempted synthesis of catalysts 212 and 213 
 
The synthesis of both these catalysts (212 and 213) was extremely problematic.  The first 
main problem encountered was the solubility of cyclohexylglycine, with heating required 
for complete dissolution.  However, the 
tBOC derivative went into solution with relative 
ease.  Methylation of both then proved to be the most complicated.  Standard methods 
using methyliodide and sodium hydride proved to be ineffective.  Heating the reaction 
mixture to reflux also had no bearing.  Alkylation with dimethyl sulphide also proved 
fruitless,  giving  exclusively  the  methyl  ester.    An  alternative  approach  using  Nosyl-
protected  derivatives 
70  in  the  presence  of  methyl  iodide,  base  and  carried  out  in 
acetonitrile  also  proved  a  failure.    In  a  dramatically  different  approach 
71,  the 
tBOC 
derivatives were first converted into the respective oxazolidinones (as in 215a,b) (scheme 
48).  The oxazolidinones were then treated with Et3SiH and trifluoroacetic acid to give 
both cleavage of the C-O bond and removal of the 
tBOC group, leaving the N-methyl 
amino acid.  Formylation was then carried out under standard methods and formation of 
the amide with 3, 5-dimethyl aniline completed using the carbodiimide method (as in 217 
to 212, 213).  However, the resulting catalysts 212 and 213 were found to be racemic, due 
to racemisation in the final step.  The mixed anhydride method also proved ineffective.  
An alternative was then used utilising the Cbz-protecting group. 
72 This proceeded well, 
forming the oxazolidinone as previously.  However, cleavage of the C-O bond proved 
very slow (~7 days at room temperature) furnishing the N-methyl amino acid 220a,b in   67 
low yield.  Subsequent amide coupling using the carbodiimide method produced 221a in 
moderate  yield  with  222b  being  formed  as  an  inseparable  mixture  with  219b.    The 
deprotection and formylation was carried out without issue to furnish 212 and 213 in good 
yield. 
 
(R)-218a, R = c-hexyl
(S)-218b, R = t-Bu
(R)-219a
(S)-219b
(R)-220a, R = c-hexyl
(S)-220b, R = t-Bu
(R)-221a, R = c-hexyl
(S)-221b, R = t-Bu
(R)-222a, R = c-hexyl, R' = H
(S)-222b, R = t-Bu, R' = H
(R)-212, R = c-hexyl, R' = CHO
(S)-213, R = t-Bu, R' = CHO
N OH
O R
Me
Cbz
N HN
O R
Me
Cbz
N O Cbz
R O
N HN
O R
R'
Me
N OH
O R
H
Cbz
(CH2O)n, CSA
PhMe, reflux Et3SiH, TFA
3,5-Me2C6H3NH2
EDCI, HOBt, Et3N
1. HCO2H, MeOH
Pd/C, rt, 2h
2. HCO2H, Ac2O
* * *
* *
 
 
Scheme 49 Synthesis of catalysts 212 and 213 
 
Both of these catalysts performed well with 212 showing similar enantioselectivities to the 
valine-derived counterpart (see table 5).  The cyclohexyl analogue 212 showed to be only 
slightly  less  efficient  that  its  isopropyl  analogue  (see  table  5)  however,  although 
exhibiting very similar activity to the valine-derived catalyst 197c, neither 212 nor 213 
were as attractive as 197c due to the cumbersome and inefficient synthesis. 
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Table 5  Reduction of imines 189c and f with ligand 212and 213.
a 
entry  imine  cat  solvent  yield 
(%)
b 
amine,  
% ee
c 
(config)
d 
1
 e  189c  (R)-212  Tol  74  89 (R) 
2
 e  189f  (R)-212  Tol  95  82 (R) 
3  189c  (S)-213  Tol
  84  82 (S) 
4  189f  (S)-213  Tol  95  83 (S) 
a The reaction was carried out at 0.5 mmol scale with 1.5 equiv of Cl3SiH and 10 mol% of the catalyst for 16 
h. 
bIsolated yield. 
cDetermined by chiral HPLC or GC. 
dEstablished from the optical rotation (measured in 
CHCl3) by comparison with the literature data (see the Experimental) and/or by HPLC/GC via comparison 
with authentic samples. 
eNote the (R) configuration of the catalyst. 
 
Another variation in the side chain was achieved by introducing an imidazole ring, starting 
from the amino acid histidine 223. 
 
NH2
HN
N
OH
O
223  
 
The imidazole moiety would hopefully provide another coordination point for the system 
and  in  turn  improve  enantioselectivity.    The  synthesis  proved  bothersome due  to  the 
basicity of the nitrogens on the imidazole ring, it was not possible to selectively alkylate 
the primary amine over the ring nitrogen.  Protection of the ring nitrogen with 
tBOC or 
Cbz, as well as mono-protection of the primary amine functionality also resulted in no 
alkylation.  Various methods of methylation were employed (described earlier, section 
2.2) but all were fruitless.  It was therefore decided that the synthesis would be carried 
forward without N-alkylation (scheme 50). 
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1. ClCO2CH3, NEt3, THF
0oC, 1h
2. 3,5-Me2C6H4, NEt3
THF, rt, 12h
CF3CO2H, 1h
ethyl formate, reflux,
12h
(27%)
(95%)
(15%)
224 225
226 223
H
 
Scheme 50 Synthesis of catalyst 223 from commercially available 224  
 
The coupling of the aniline to furnish 225 was carried out using the same mixed anhydride 
procedure as used previously.  The N-
tBOC group was then removed with trifluoroacetic 
acid and formylation completed by refluxing the free amine with ethyl formate.  Refluxing 
was  essential  in  this  case  due  to  the  insoluble  nature  of  the  compound.    The  final 
compound was then purified by crystallisation from methanol.  Only a small amount was 
isolated (>85mg) however. 
 
2.4 Imidazole Catalyst Investigations 
 
Turning briefly away from ketimine reductions, it was decided that 223 would be used to 
try and facilitate the Strecker type cyanation (scheme 51) 
 
N HN
CN
TMSCN, 223, solvent
rt, 16 h
189a 227  
 
Scheme 51 Strecker type cyanation with catalyst 223 
 
The reaction was firstly carried out in toluene however, no reaction was observed.  The 
solvent was then switched to chloroform but as before, no reaction was observed.  An   70 
allylation (Sakurai type) on the aldimine 228 was then attempted (Scheme 52) which also 
resulted in no reaction.   
 
N HN
R = Me3, Cl3
228 229
SiR3 , solvent
223, rt, 16 h
H
 
 
Scheme 52 Allylation of aldimines 228 
 
These results were, of course very disappointing as it was expected that the reactions 
would  proceed  irrespective  of  whether  or  not  chirality  was  induced.    However,  we 
believed that the lack of catalysis was due to the insolubility of the catalyst itself.  Work 
carried out by Brook and co-workers 
73 on ketone reduction using extracoordinate silicon 
showed that using neutral imidazole derivatives could not trigger reduction of ketones 
with  alkoxysilanes.    However,  the  corresponding  imidalozide  anions  were  shown  to 
activate the said reductions.  This concept was utilised, not only to aid reactivity, but the 
formation of the imidalozide anion in catalyst 223 could assist dissolution.  A series of 
reductions and allylations were attempted using this model as shown in scheme 53.  
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Scheme 53 Reduction and allylation with 223 using the Brooks model 
 
As can be seen from scheme 53, the reduction of 189a and the allylation of 107 and 231 
did not proceed at all.  In contrast, the reduction of acetophenone 57 did give the resulting 
alcohol but in poor enantioselectivity (2% ee).  The reaction itself was also very sluggish 
as indicated by TLC.  It is clear that further development of this catalyst will be required 
to address the solubility issue as well as trying to make it a more efficient catalyst. 
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2.5 Mechanistic Observations 
 
The experiments carried out so far indicate key points in both the catalyst and substrate 
that are essential for the protocol to work (see fig. 12).   
 
The catalyst requires two amide functionalities for an effect to be realised.  One must be of 
the formamide type and the other an anilide.  Without either the formamide or the anilide, 
chiral  induction  will  not  occur  (in  the  case  of  206)  and  in  some  cases  will  not  even 
catalyse the reduction (in the case of 197d and 208b).  These are assumed to be required 
as donors for coordination to HSiCl3.  NMR investigation strengthened this assumption.  
The 
13C NMR spectrum of a 1:1 mixture of 197c and HSiCl3 indicated that the carbonyls 
of the formamide and anilide shifted by ~0.1 and 0.2 ppm respectively in relation to the   72 
free catalyst and indeed, the methyl groups on the aromatic ring became non-equivalent.  
In the free catalyst, the two methyl groups show as a single peak at 21.71 ppm but in the 
mixture they split in to two peaks showing at 21.69 and 21.76 ppm.  This suggests a weak 
coordination that may restrict rotation around the N-aromatic bond. 
 
Having the correct balance of steric and electronic properties on the N-aromatic ring also 
plays a major part.  Keeping the formamide portion constant and altering the aromatic ring 
gave insight into how changing the ring donor properties affected catalysis.  By adding 
electron-withdrawing  (197e)  and  electron-donating  (197b)  groups,  it  was  shown  that 
efficiency was decreased in both cases compared to that of the parent catalyst (197a).  
Inclusion  of  the  withdrawing  groups  however,  led  to  a  greater  degree  of  inefficiency 
suggesting that it did not coordinate well.  The 3,5-dimethyl  catalyst  197c appears to 
contain the correct balance of steric and electronic properties. 
 
The tertiary versus secondary anilide question was also investigated.  It was shown that 
the  secondary  anilides  (197a-c,e)  were  efficient  catalysts  whilst  the  tertiary  anilides 
(203a-b) were not.  It would appear that the N-H bond plays a key role in the catalyst 
activity, whether through hydrogen bonding or indeed just allowing the amide bond to 
rotate more freely.  However, as mentioned previously, the amide must be aromatic since 
replacing  the  aromatic  moiety  with  an  aliphatic  one  (197d)  rendered  the  catalyst 
ineffective. 
 
The tertiary formamide portion also appears to be vital to catalyst activity.  There are two 
requirements for the formamide group however.  It must be adequately Lewis-basic and 
must be suitably small.  Catalyst  205 demonstrates the first  provision.  The  electron-
withdrawing trifluoromethyl group makes the formamide much less Lewis-basic and as a 
result renders the catalyst ineffective.  The phenylglycine-derived catalyst 208a is also 
ineffective in producing chiral induction.  On comparison to the parent catalyst 197a, it is 
apparent that the added bulk around the amide portion is a limiting factor.  This is also 
evident in the urea derivative 206, which again is shown to be ineffective. 
 
The N-methyl moiety is also important in terms of enantioselectivity.  The synthesis of 
catalyst 207, lacking the N-methyl group proved to be effective at catalysing the reduction 
but was poor at inducing chirality (comparing the reductions with 197b and 207).  It is 
apparent that the methyl group helps to provide the correct conformation of the formamide   73 
to convey the chiral information from the chiral centre.  Without it, chiral induction is 
more sluggish. 
 
The  side  chain  of  the  amino  acid  provided  the  most  interesting  observation.    Larger 
substituents such as isopropyl (197a-e, 203a-b and 207) from valine, cyclohexyl (212), 
tert-butyl  (213),  benzyl  (208b)  and  iso-butyl  (208d)  all  functioned  to  form  the  same 
configuration of amine.  However, the single methyl group (208c) from alanine induced 
the formation of the opposite enantiomer of amine.  This was also noticed, as mentioned 
previously, when the proline-derived catalysts (202a-b) were used. 
9     We believe that 
there is no conformational bias created between the N-alkyl group and the alkyl group  to 
the nitrogen of the catalyst.  This allows the two groups to remain close to each other, and 
not be forced away as in the more bulky catalysts.  This would account for the opposite 
configuration of the amine product.  At the borderline lies the phenylglycine derivative 
(208a).  Use of this catalyst gave racemic product.  It is clear that the phenyl group at the 
-position provides too much steric bulk for the catalyst to induce any stereocontrol.  The 
side chain appears therefore, to be directly involved in determining enantiodifferentiation.  
By altering the side chain, subtle changes in the conformation of the catalyst can result in 
differing enantiomers of product. 
 
The structure of the substrate ketimine also plays an important role.  The R
1 group (see 
scheme 42) should be aromatic preferably (189a-d) which gives better results in terms of 
conversion  and  enantioselectivity.    However,  non-aromatic  groups  (189e)  can  be 
employed here but at the cost of lower enantioselectivity.  The aromatic groups can also 
endure  electron-withdrawing  (189c)  and  donating  (189b)  substituents  well,  with  the 
former performing slightly better.  With respect to the R
2 substituents, the inclusion of an 
aromatic group attached directly to the N was crucial.  Examination of imines 189a,f,g 
showed that  whilst  189a (containing  a  N-phenyl moiety) and  189f (containing  a  N-p-
methoxyphenyl moiety) gave comparable, high enantioselectivities on reduction,  189g 
(with  a  N-o-methoxyphenyl  moiety)  gave  considerably  lower  enantioselectivities  and 
reaction rate (table 1, entries 2, 12, 13).  This would indicate that steric congestion around 
the N is not favourable and should be avoided.  The high enantioselectivities obtained with 
the p-methoxypheny ketimine 189f is of even greater importance since electron-rich N-
aromatic groups such as p-methoxyphenyl can be removed by oxidative methods (using 
CAN).
74 This gives the opportunity to extend the protocol to the production of primary 
amines. 
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Figure 12 Key features of the catalyst and imine 
 
Since clearly the 3,5-dimethylanilide catalyst 197c had performed best both in terms of 
reactivity and ability to induce chirality into a substrate, its scope was briefly investigated 
using a chalcone-based imine 233 and a phenylglycine-based imine 234.  
 
N N
O
O
233 234  
 
The reasons for the choice of these two substrates were that in the case of 233 we could 
further look at the effect of changing R
1 (scheme 42) to include conjugation.  Also if the 
conjugated olefin remained intact then that could pave the way for more chemistries to be 
carried out (epoxidation, hydroxylation etc.).  For 234, if the reduction was successful then 
deprotection of the N-aryl moiety could give access to chiral -amino acids.  The imines 
were reduced using the standard reduction protocol and the results shown in table 6.  With 
the chalcone derivative 233, the reduction proceeded smoothly at ambient temperature but 
with reduced enantioselectivity (74% ee).  However, lowering the temperature to -20
oC 
had the effect of increasing the enantioselectivity to 81% ee (table 6, entries 1, 2).  Most 
interesting  was  that  the  olefin  remained  intact.    The  reduction  of  the  phenylglycine 
derivative
  234  was  not  as  effective.    Reduction  at  room  temperature  gave  poor 
enantioselectivity  (30%  ee)  but  good  reactivity  (68%  after  16h).    Lowering  the   75 
temperature to -20
oC did increase the enantioselectivity almost two-fold (59% ee) (table 
3.3.6, entries 3, 4) but this was to the detriment of reactivity (69% after 24h). 
 
Table 6 Reduction of imines 233 and 234 with catalyst 197c.
 a 
entry  imine  temp 
(
oC) 
yield 
(%)
b 
 % ee
c 
(config)
d 
1  233  ambient  59  74 (S) 
2  233  –20  64  81 (S) 
3  234  ambient  68  30 (R)
e 
4  234  –20  69  59 (R)
e,f 
aThe reaction was carried out at 0.5 mmol scale with 1.5 equiv of Cl3SiH and 10 mol% of the catalyst in 
toluene for 16 h. 
bIsolated yield. 
cDetermined by chiral HPLC or GC. 
dEstablished from the optical rotation 
(measured in CHCl3) by comparison with the literature data (see the Experimental) and/or by HPLC/GC via 
comparison with authentic samples. 
eNote the change of substituent priorities in the CIP nomenclature. 
fThe 
reaction was run for 24 h. 
 
The  result  of  the  chalcone  derivative  233  also  shows  that  although  when  the  imine 
substituent R
1 (scheme 31) is non-aromatic and enantioselectivities decrease, extending 
the conjugation has the effect of increasing the enantioselectivity back up to acceptable 
levels, showing that conjugation is valuable. 
 
 
2.6 Nonlinear effect (NLE) investigation 
 
Until  about  twenty  years  ago,  no  organic  chemist  would  have  thought  that  a  chiral 
catalyst/auxiliary with a low enantiopurity could induce chirality into a substrate higher 
than its own or indeed to the same level as if an enantiopure catalyst was used!  This 
phenomenon whereby the relationship between the ee of the catalyst and the ee of the 
product  deviates  from linearity has  given rise to what  is  now called nonlinear effects 
(NLEs).    This  effect  reflects  the  complexity  of  molecular  interactions  and  reaction 
mechanisms.    However,  it  can  be  used  to  generate  products  with  high  ee‟s  from 
enantiomerically impure catalysts.  Most importantly, NLEs can be used as a probe to 
obtain details on mechanisms that are involved in creating chirality. 
Kagan et al 
75 challenged the assumption that the maximum ee of a product could only be 
obtained if an enantiopure catalyst was used.  Kagan showed that this was not always the 
case and the linear relationship between the catalyst ee and the substrate ee could in fact 
be deviated from.  From data collected from various experiments, it was concluded that   76 
deviations from linearity would result in either a plain curve either above ((+)-NLE) or 
below ((-)-NLE) the straight line (figure 13)  
 
ee% cat.
ee% 
prod.
(+)-NLE
(-)-NLE
 
 
Figure 13 Curves showing typical (+) and (-)-nonlinear effects 
 
Of course, the curves shown are simplified and more complicated examples exist that 
don‟t follow the clear-cut positive and negative curves.  However, figure 13 gives a good 
illustration  of  the  power  of  the  nonlinear  effect.    For  example,  if  a  system  could  be 
designed that follows a (+)-NLE then an enantiomerically impure catalyst could be used to 
furnish a product in high enantioselectivity.  Of course, the opposite could be found if a (-
)-NLE was in play.  A NLE an also give insight into the mechanism of how a reaction 
proceeds.    If  a  linear  correlation  is  found  then  it  suggests  that  only  one  molecule  of 
catalyst is involved in the enantiodifferentiating process.  For this reason it was decided 
that an NLE study on our system would be beneficial and help provide some more insight 
to our catalytic system. 
 
The NLE investigation was carried out using the reduction of 189c as the model reaction.  
Catalyst 197c, at varying degrees of enantiopurity
1 (100-0% ee), was then used to catalyse 
the reduction under the standard protocol and the results plotted in a scatter graph (see 
graph 1). 
 
                                                 
1 Assuming 197c is 100% enantiopure, mixing with racemic 197c at various ratios will lower the ee of the 
catalyst (100%-0 at intervals of 10%)   77 
 
 
Graph 1 Results of NLE study using 197c 
 
From the results obtained, a linear correlation between product ee and catalyst ee was 
evident.  This, as stated previously suggests that only one molecule of 102c is involved in 
the enantiodifferentiating process. (It should be noted that the points deviating from the 
straight line are most likely due to experimental error during the preparation of the catalyst 
ratios). 
 
2.7 Further investigation into protocol scope   
 
To investigate further uses of catalyst 197c, a series of epoxide ring opening reactions 
were attempted.  Using both HSiCl3 and SiCl4 , ring openings on cis-stilbene oxide 235 
and cyclooctene oxide 237 were carried out (see scheme 54). 
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Scheme 54 Epoxide ring-opening reactions  
 
Although mostly racemic products were obtained, the ring opening of cis-stilbene oxide 
with HSiCl3 in toluene at room temperature showed promise (giving product in 32% ee) 
and with further catalyst development, it may be possible to increase this further yet. 
 
A series of aziridinations and epoxidations were carried out in order to determine whether 
or not catalyst 197c could facilitate these transformations. 
76 The reactions carried out are 
shown in Scheme 55. 
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Scheme 55 Aziridination and epoxidation facilitated by catalyst 197c 
 
Use of trichloro(chloromethyl)silane in the presence of catalyst 197c proved friutless. This 
was also the case when carried out at -20
oC.  An alternative strategy was then employed.  
Utilising the asymmetric Simmons-Smith cycloproponation protocol (Scheme 56)
77 using 
diethyl zinc and diiodomethane, in the presence of 197c the aziridination of aldimines 242 
was attempted.   
 
R1
R2 N
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Scheme 56 Asymmetric Simmons-Smith cycloproponation  
 
It was postulated that this protocol would suit our catalytic system since Shi et al had 
shown that a simple didpeptide 244, on treatment with ZnEt2 and CH2I2 could facilitate the 
cycloproponation of unfunctionalised olefins in high enantioselectivity.   This catalyst had 
a similar framework to our catalyst 197c and it was therefore assumed that it might behave 
in a similar manner.  However, this proved not to be the case.  Indeed, in the presence of 
our catalyst, the reaction failed to proceed at all.  This line of investigation was taken no 
further. 
   80 
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On-going  work  within  the  group 
67  on  ketone  reduction  (scheme  57)  prompted  us  to 
consider the use of 102c in the said reduction.  The reaction, on acetophenone was carried 
out in the same way as the ketimine reductions (HSiCl3, 10mol% 197c).   
 
O OH
HSiCl3, 197c (10 mol%)
RT, 16h, toluene
57 58  
Scheme 57 Asymmetric ketone reduction with catalyst 197c 
 
Results from work carried out during an undergraduate project on ketone reduction (using 
197a) suggested that the reduction would not proceed.  However, since our champion 
catalyst had not been used it was thought prudent that this should be attempted.  The 
reduction proceeded well, furnishing the alcohol 58 in modest enantioselectivity (41% ee).   
 
As a final exploration into the variety of different asymmetric transformations that could 
be facilitated, the Strecker-type cyanation was attempted.  Ketimine 189a was subjected to 
similar  reaction  conditions  as  previously  used  and  although  the  reaction  proceeded  to 
completion,  the  resulting  cyano-compound  was  found  to  be  racemic.    No  further 
investigation into the Strecker-type cyanation was carried out.  
 
Owing to the successful reduction of the ,-unsaturated imine 233 whilst leaving the 
unsaturated  double  bond  intact,  it  was  decided  that  a  range  of  imines  containing  an 
unsaturated double bond would be synthesised and subsequently tested. 
 
N
233  
   81 
Beginning with the homoallylic framework (cf. 245), the following series of imines were 
hoped to be produced (245, 246 and 247). 
 
N
Ar
Ar1 N
Ar
Ar1 N
Ar
Ar1
245 246 247  
For the homoallylic series, the synthesis began with the allylation of the corresponding 
aldehyde  under  Lewis  basic  allylation  conditions.
78  Using  DMF  as  the  Lewis  base, 
allylation of the aldehyde with allyltrichlorosilane afforded the corresponding homoallylic 
alcohol in moderate yields.  The oxidation to the ketone proved troublesome at first with 
methods  such  as  PDC  oxidation,  Swern,  Oppenhauer 
79  and  oxidation  with  calcium 
hypochlorite 
80 all giving inferior results.  Literature precedence of oxidations of similar 
alcohols with PCC 
81 prompted us to try this method and subsequently the oxidations were 
successful,  with  excellent  yields  and  reaction  times  of  ≤3  hours.    A  representative 
synthetic scheme is shown below (Scheme 58). 
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Scheme 58. Representative synthesis of homoallylic imines 245 
 
The synthesis of frameworks 246 and 247 were slightly different in that the alkyl chain 
was incorporated on to the aldehyde via a Grignard reaction. 
82 Using the appropriate 
bromo alkene (4-bromobut-1-ene for 246 and 5-bromopent-1-ene for 246) and magnesium 
turnings, the Grignard reagent was synthesised and to this was added the aldehyde to 
furnish the corresponding alcohols with moderate yields in ~3.5 hours.  The oxidation step 
used was as in Scheme 58.  The representative scheme for the synthesis of frameworks 
246 and 247 is shown in Scheme 59.   82 
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Scheme 59. Representative synthesis of 246 and 247 
 
The imine synthesis to date has proven difficult.  With the simpler acetophenone based 
imines the transformation was complete and almost quantitative in ≤ 12 hours.  However, 
with the allylic ketones and longer chain ketones the imine synthesis has proved sluggish 
with ~50% conversion achieved in 2 days.  Different strategies have been employed in an 
attempt  to  remedy  this  with  differing  results.    The  Dean  and  Stark  protocol,  which 
involves azeotropic removal of water afforded no product.  The imine has also proved 
difficult to separate from the starting ketone as both starting material and product have 
similar Rf values on TLC.  Owing to time constraints, unfortunately this could not be 
continued. 
 
2.8 Conclusion 
 
We  have  designed  new  amino  acid  derived  organocatalysts  197  that  are  capable  of 
catalysing the reduction of a range of aromatic imines to the corresponding secondary 
amines by way of hydrosilylation of N-aryl ketimines with HSiCl3.  A proposed transition 
state for this is shown below in figure 14. 
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Figure 14 Proposed transition state for catalyst interaction with imine and HSiCl3. 
 
We have achieved enantioselectivities of 93% ee which match and indeed surpass some 
well  established  metal-mediated  protocols.
2  The  valine-derived  formamide  197c 
performed best with toluene as the solvent of choice.  With the system being metal free 
and  the  solvent  being  environmentally  sound,  we  have  developed  an  efficient  and 
workable  alternative  to  metal-mediated  ketimine  reduction.    Further  development  has 
continued with the synthesis of catalyst 213, the 3,5-di-tert-butyl anilide derivative of 197. 
83 This has been utilised successfully in the aziridination of -chloroketones, via reductive 
amination.  This again shows the strength and depth of our protocol. 
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The synthesis of catalyst 197c is now also being scaled up to the multi-gram level and is in 
the process of being made available commercially.  When this project was embarked on, 
the aim was to provide an environmentally friendly alternative to metal-mediated ketimine 
reduction that could be utilised in an industrial setting.  Perhaps we are almost there! 
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Chapter 3: Experimental 
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3. Experimental Section 
 
General  Methods. Melting points  were determined on a Kofler block  and are 
uncorrected.  Optical  rotations  were  recorded  in  CHCl3  at  25  C  unless  otherwise 
indicated, with an error of ≤0.1. The [ʱ]D values are given in 10
-1 deg cm
3 g
-1. The NMR 
spectra were recorded in CDCl3, 
1H at 400 MHz and 
13C at 100.6 MHz with chloroform-
d1 (ʴ 7.26, 
1H; ʴ 77.0, 
13C) as internal standard unless otherwise indicated. Various 2D-
techniques and DEPT experiments were used to establish the structures and to assign the 
signals. The IR spectra were recorded for CHCl3 solutions unless otherwise indicated. The 
mass spectra (EI and/or CI) were measured on a dual sector mass spectrometer using 
direct inlet and the lowest temperature enabling evaporation. All reactions were performed 
under  an  atmosphere  of  dry,  oxygen-free  nitrogen  in  oven-dried  glassware,  twice 
evacuated and filled with inert gas. Solvents and solutions were transferred by syringe-
septum and cannula techniques. All solvents for the reactions were of reagent grade and 
were dried and distilled immediately before use (dichloromethane from calcium hydride). 
Petroleum ether refers to the fraction boiling in the range of 60-80 
oC. Yields are given for 
isolated products showing one spot on a TLC plate and no impurities detectable in the 
NMR spectrum. The identity of the products prepared by different methods was checked 
by comparison of their NMR, IR, and MS data and by the TLC behaviour. The chiral GC 
and HPLC methods were calibrated with the corresponding racemic mixtures. The imines 
are known compounds and were prepared according to the procedure shown for 103c, the 
only  new  member  of  this  series.  Amines  are  all  know  compounds  and  their  absolute 
configuration was established in reference to the literature data. 
 
N
F3C  
 
N-(1-(4-(trifluoromethyl)phenyl)ethylidene)benzenamine 189c A mixture of NaHCO3 
(2.2 g, 26 mmol), aniline (0.48 mL, 5.3 mmol), p-trifluoromethylacetophenone (1.0 g, 5.3 
mmol), and activated molecular sieves (4 g, 4 Å) in anhydrous toluene (5 mL) was heated 
at 80 
oC for 12 h under an argon atmosphere. The mixture was filtered through celite and 
the celite washed with CH2Cl2. The filtrate was evaporated in vacuo and the product was   86 
crystallized from petroleum ether at 5 
oC to give pure 189c (0.67 g, 48%): mp 74-77 
oC; 
1H NMR (400 MHz, CDCl3) ʴ 2.17 (s, 3H), 6.71 (d, J = 8.0 Hz, 2H), 7.03 (t, J = 8.0 Hz, 
1H), 7.30 (t, J = 8.0, 2H), 7.61 (d, J = 8.2 Hz, 2H), 7.99 (d J = 8.2, 2H); 
13C NMR ʴ 17.80 
(CH3), 119.57 (CH), 124.04 (CH), 125.72 (CH), 127.92 (CH), 129.44 (CH), 132.31 (CF3), 
143 (C), 151.51 (C), 164.69 (C); IR (NaCl) ν 1643 cm
-1; MS m/z (%) 263.1 (M
+, 61%) 
248.1  (100),  244.1  (7),  152.1  (4),  181.1  (16),  77.1  (71);  HRMS  (EI):  263.0922 
(C15H12N2F3 requires 263.0921). 
 
N
 
 
General procedure for the synthesis of imines: Phenyl-(1-phenyl-ethylidene)-amine 
(189a). In a typical experiment NaHCO3 (8.2 g, 98 mmol), aniline (1.82 mL, 20 mmol), 
acetophenone (2.34 mL, 20 mmol), activated molecular sieves (14 g, 4 Å) and anhydrous 
toluene were heated at 80 
oC under an argon atmosphere. The mixture of reaction was 
filtered through celite and the celite washed with DCM. The filtrate was evaporated in 
vacuo and the product 189a was crystallised in petroleum ether at –20 
oC; 
1H NMR (400 
MHz, CDCl3)  2.26 (s, 3H), 6.81 (d, J= 8.1Hz, 2H), 7.12 (t, J= 7.1Hz, 1H), 7.39 (t, J= 
7.3Hz, 2H), 7.45 (m, 3H), 8.0 (d, J= 8.1Hz, 2H) in agreement with literature values. 
84 
 
N
O  
 
[1-(4-Methoxy-phenyl)-ethylidene]-phenyl-amine  (189b).  Prepared  according  to  the 
general procedure. 
 
  NaHCO3 (8.2 g, 98 mmol); 
  aniline (1.82 mL, 20 mmol); 
  (4-methoxy)-acetophenone (3.0 g, 20 mmol); 
  toluene (8 mL); 
  MS 4 A (14 g)   87 
The mixture of reaction was filtered through celite and the celite washed with DCM. The 
filtrate was evaporated in vacuo and the product 189b was crystallised in petroleum ether 
at 5 
oC; 
1H NMR (400 MHz, CDCl3)  2.22 (s, 3H), 3.90 (s, 3H), 6.80 (d, J= 7.1Hz, 2H), 
6.98 (d, J= 6.9Hz, 2H), 7.09 (t, J= 7.4Hz, 1H), 7.34 (t, J= 7.2Hz, 2H), 7.97 (d, J= 7.9Hz, 
2H) in agreement with literature values. 
60 
 
N
 
 
(1-Naphthalen-2-yl-ethylidene)-phenyl-amine (189d). Prepared according to the general 
procedure. 
 
  NaHCO3 (8.2 g, 98 mmol); 
  aniline (1.82 mL, 20 mmol) 
  2-acetophanone (3.4 g, 20 mmol); 
  toluene (8 mL); 
  MS 4 A (14 g) 
 
The mixture of reaction was filtered through celite and the celite washed with DCM. The 
filtrate was evaporated in vacuo and the product 189d was crystallised in petroleum ether 
at room temperature; 
1H NMR (400 MHz, CDCl3)  2.38 (s, 3H), 6.86 (d, J= 8.1Hz, 2H), 
7.13 (t, J= 7.4Hz, 1H), 7.42 (t, J= 7.3Hz, 2H), 7.53 (m, 2H), 7.92 (m, 3H), 8.22 (d, J= 
7.9Hz, 1H) in agreement with literature values. 
60 
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(4-Methoxy-phenyl)-(1-phenyl-ethylidene)-amine  (189f).  Prepared  according  to  the 
general procedure. 
  NaHCO3 (8.2 g, 98 mmol); 
  p-anisidine (2.46 g, 20 mmol);   88 
  acetophenone (2.34 mL, 20 mmol); 
  toluene (8 mL); 
  MS 4 A (14 g) 
 
The mixture of reaction was filtered through celite and the celite washed with DCM. The 
filtrate was evaporated in vacuo and the product 189f was crystallised in petroleum ether 
and ethyl acetate at room temperature; 
1H NMR (400 MHz, CDCl3)  2.28 (s, 3H), 3.84 (s, 
3H), 6.77 (d, J= 7.9Hz, 2H), 6.94 (d, J= 7.8Hz, 2H), 7.47 (m, 3H), 7.98 (d, J= 7.4, 2H) in 
agreement with literature values. 
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(2-Methoxy-phenyl)-(1-phenyl-ethylidene)-amine  (189g).  Prepared  according  to  the 
general procedure. 
 
  NaHCO3 (8.2 g, 98 mmol); 
  o-anisidine (2.26 mL, 20 mmol); 
  acetophenone (2.34 mL, 20 mmol); 
  toluene (8 mL); 
  MS 4 A (14 g) 
 
The mixture of reaction was filtered through celite and the celite washed with DCM. The 
filtrate  was  evaporated  in  vacuo  and  the  product  189g  was  distilled  under  reduced 
pressure. 
85 
 
 
 
 
   89 
N
 
 
(1-Cyclohexyl-ethylidene)-phenyl-amine  (189e).  Prepared  according  to  the  general 
procedure. 
 
  NaHCO3 (8.2 g, 98 mmol); 
  aniline (1.82 mL, 20 mmol); 
  1-cyclohexyl-ethanone (2.75 mL, 20 mmol); 
  toluene (8 mL); 
  MS 4 A (14 g) 
 
The mixture of reaction was filtered through celite and the celite washed with DCM. The 
filtrate  was  evaporated  in  vacuo  and  the  product  189e  was  distilled  under  reduced 
pressure.  
1H NMR (400 MHz, CDCl3)  1.05-2.40 (m, 11H), 1.72 (s, 3H), 6.69 (d, J= 
8.4Hz, 2H), 7.05 (t, J= 8.8Hz, 1H), 7.29 (t, J= 10.0Hz, 2H) in agreement with literature 
values. 
60 
 
N
 
 
Cyclohexyl-(1-phenyl-ethylidene)-amine  (189h).  Prepared  according  to  the  general 
procedure. 
 
  NaHCO3 (8.2 g, 98 mmol); 
  cyclohexylamine (2.28 mL, 20 mmol); 
  acetophenone (2.34 mL, 20 mmol); 
  toluene (8 mL); 
  MS 4 A (14 g) 
   90 
The mixture of reaction was filtered through celite and the celite washed with DCM. The 
filtrate  was  evaporated  in  vacuo  and  the  product  189h  was  distilled  under  reduced 
pressure.  
1H NMR (400 MHz, CDCl3)   1.25-1.91 (m, 10H), 2.27 (s, 3H), 3.51 (m, 1H), 
7.40 (m,3H), 7.78 (t, J= 7.6Hz, 2H) in agreement with literature values. 
60 
 
 
N
 
 
Butyl-(1-phenyl-ethylidene)-amine (189i). Prepared according to the general procedure. 
 
  NaHCO3 (8.2 g, 98 mmol); 
  Butylamine (2.0 mL, 20 mmol); 
  acetophenone (2.34 mL, 20 mmol); 
  toluene (8 mL); 
  MS 4 A (14 g) 
 
The mixture of reaction was filtered through celite and the celite washed with DCM. The 
filtrate was evaporated in vacuo and the product 189i was distilled under reduced pressure; 
1H NMR (400 MHz, CDCl3)  0.85 (t, J= 7.8Hz, 3H), 1.45 (m, 2H), 1.74 (m, 2H), 2.26 (s, 
3H), 3.50 (t, J= 7.2Hz, 2H), 7.39 (m, 3H), 7.78 (m, 2H) in agreement with literature 
values. 
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N
 
 
Benzyl-(1-phenyl-ethylidene)-amine  (189j).  Prepared  according  to  the  general 
procedure. 
 
  NaHCO3 (8.2 g, 98 mmol); 
  benzylamine (2.2 mL, 20 mmol); 
  acetophenone (2.34 mL, 20 mmol); 
  toluene (8 mL); 
  MS 4 A (14 g)   91 
The mixture of reaction was filtered through celite and the celite washed with DCM. The 
filtrate  was  evaporated  in  vacuo  and  the  product  189j  was  distilled  under  reduced 
pressure; 
1H NMR (400 MHz, CDCl3)  2.39 (s, 3H), 4.81 (s, 2H), 7.28 (t, J= 7.67Hz, 
2H), 7.38 (d, J=7.3Hz, 2H), 7.41 (t, J= 7.6Hz, 4H), 7.48 (d, J= 7.5Hz, 2H) in agreement 
with literature values. 
60 
 
Protocol A: General Procedure for the Catalytic Hydrosilylation of Imines. 
Trichlorosilane (77 μL, 0.77 mmol) was added dropwise to a stirred solution of the imine 
(0.51 mmol) and the catalyst (0.051 mmol) and in anhydrous CH2Cl2 (or CHCl3 or MeCN 
or toluene; see tables 1-5) at 0 
oC (or at -20 
oC), and the mixture was allowed to stir 
overnight at room temperature (or at -20 
oC) under an argon atmosphere. The reaction was 
quenched with a saturated solution of NaHCO3 (10 mL) and the product was extracted 
with ethyl acetate (100 mL). The extract was washed with brine and dried over anhydrous 
MgSO4 and the solvent was evaporated. Purification using column chromatography on 
silica gel with a petroleum ether-ethyl acetate mixture (24:1) afforded the product as an 
oil. The yields and ee are given in Tables 1-4.  
 
HN
*
 
 
(S)-(+)-N-(1-phenylethyl)benzenamine 190a. [ʱ]D +16.8 (c 0.5, MeOH); 
1H NMR (400 
MHz, CDCl3) ʴ 1.41 (d, J = 7.1 Hz, 3H), 3.94 (br s, 1H), 4.41 (q, J = 6.7 Hz, 1H), 6.44 (d, 
J = 8.6 Hz, 2H), 6.57 (t, J = 7.3 Hz, 1H), 7.01 (t, J = 7.5 Hz, 2H), 7.13 (t, J = 6.8 Hz, 1H), 
7.27 (t, J = 7.3 Hz, 2H), 7.30 (d, J = 7.3 Hz, 2H) in agreement with the literature data;
86 
chiral HPLC (Chiralcel OD-H, hexane/2-propanol 15:1 + 0.1% NEt3, 0.5 mL/min) showed 
92% ee (tS = 15.1 min, tR = 17.7 min). 
 
HN
O
*
 
   92 
(S)-(+)-N-(1-(4-methoxyphenyl)ethyl)benzenamine 190b. [ʱ]D +4.45 (c 0.5, MeOH); 
1H 
NMR (400 MHz, CDCl3) ʴ 1.38 (d, J = 7.2 Hz, 3H), 3.68 (s, 3H), 3.90 (br s, 1H), 4.35 (q, 
J = 6.6 Hz, 1H), 6.41 (d, J = 8.5 Hz, 2H), 6.55 (t, J = 7.31 Hz, 1H), 6.77 (d, J = 7.2 Hz, 
2H), 6.97 (t, J = 6.5 Hz, 2H), 7.14 (d, J = 7.2 Hz, 2H) in agreement with the literature 
data;
60,84  chiral  HPLC  (Chiralcel  OD-H,  hexane/2-propanol  15:1  +  0.1%  NEt3  0.5 
mL/min) showed 80% ee (tS = 19.3 min, tR = 22.7 min). 
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F3C
*
 
 
(S)-(+)-N-(1-(4-(trifluoromethyl)phenyl)ethyl)benzenamine  190c.  [ʱ]D  +20.0  (c  0.5, 
CHCl3); 
1H NMR (400 MHz, CDCl3) ʴ 1.46 (d, J = 7.1 Hz, 3H), 3.97 (br s, 1H), 4.46 (q, J 
= 6.7 Hz, 1H), 6.38 (d, J = 7.6 Hz, 2H), 6.59 (t, J = 7.4 Hz, 1H), 7.02 (t, J = 7.3 Hz, 2H), 
7.41 (d, J = 8.2 Hz, 2H), 7.51 (d, J = 8.2 Hz, 2H) in agreement with the literature data;
86 
chiral GC (Supelco β-DEX 120 column, oven: 125 
oC for 2 min, then 1
 oC/min to 200 
oC, 
10 min at that temperature) showed ee of 89% (tS = 42.8 min, tR = 43.2 min). 
 
HN
*
 
 
(S)-(+)-N-(1-(naphthalen-2-yl)ethyl)benzenamine 190d. [ʱ]D +16.2 (c 1.0, MeOH); 
1H 
NMR (400 MHz, CDCl3) ʴ 1.49 (d, J = 7.1 Hz, 3H), 4.03 (br s, 1H), 4.54 (q, J = 6.7 Hz, 
1H), 6.45 (d, J = 8.0 Hz, 2H), 6.56 (t, J = 7.5 Hz, 1H), 6.98 (t, J = 7.6 Hz, 2H), 7.30 (t, J = 
7.8 Hz, 2H), 7.36 (d, J = 7.2 Hz, 2H), 7.69 (d, J = 7.8 Hz, 2H), 7.70 (s, 1H) in agreement 
with  the  literature  data;
86,87  chiral  HPLC  (Chiralcel  OD-H,  hexane/2-propanol  15:1  + 
0.1% NEt3, 0.5 mL/min) showed 88% ee (tS = 18.7 min, tR = 21.2 min). 
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(S)-(+)-N-(1-cyclohexylethyl)benzenamine  190e.  [ʱ]D  +6.1  (c  1.0,  CHCl3); 
1H  NMR 
(400 MHz, CDCl3) ʴ 0.91-1.80 (m, 11H), 1.05 (d, J = 6.7 Hz, 3H), 3.2 (q, J = 8.0 Hz, 1H), 
3.38 (br s, 1H), 6.49 (d, J = 8.0 Hz, 2H), 6.55 (t, J = 8.0 Hz, 1H), 7.07 (t, J = 10.0 Hz, 2H) 
in agreement with the literature data;
61 chiral HPLC (Chiralcel OD-H, hexane/2-propanol 
99:1, 0.75 mL/min) showed 37% ee (tR = 8.2 min, tS = 8.7 min). 
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(S)-(+)-4-methoxy-N-(1-phenylethyl)benzenamine 190f. [ʱ]D +2.5 (c 1.0, MeOH); 
1H 
NMR (400 MHz, CDCl3) ʴ 1.40 (d, J = 7.0 Hz, 3H), 3.60 (s, 3H), 4.32 (q, J = 6.4 Hz, 1H), 
6.37 (d, J = 8.1 Hz, 2H), 6.61 (d, J = 7.6 Hz, 2H), 7.15 (t, J = 7.4 Hz, 1H), 7.22 (t, J = 7.4 
Hz, 2H), 7.28 (d, J = 7.6 Hz, 2H) in agreement with the literature data;
86,88. chiral HPLC 
(Chiralcel OD-H, hexane/2-propanol 99:1, 0.75 mL/min) showed 85% ee (tR = 15.5 min, 
tS = 18.6 min). 
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(S)-(+)-2-methoxy-N-(1-phenylethyl)benzenamine 190g.  [ʱ]D +9.2 (c 0.5, CHCl3); 
1H 
NMR (400 MHz, CDCl3) ʴ 1.44 (d, J = 7.1 Hz, 3H), 3.80 (s, 3H), 4.38 (q, J = 6.8 Hz, 1H), 
4.54 (br s, 1H), 6.25 (d, J = 8.0 Hz, 1H), 6.52 (t, J = 6.9 Hz, 1H), 6.61 (t, J = 7.2 Hz, 1H), 
6.69 (d, J = 7.1 Hz, 1H), 7.12 (t, J = 7.5 Hz, 1H), 7.24 (t, J = 7.2 Hz, 2H), 7.33 (d, J = 7.2 
Hz, 2H) in agreement with the literature data;
89 chiral HPLC (Chiralcel OD-H, hexane/2-
propanol 99:1, 0.75 mL/min) showed 22% ee (tS = 7.1 min, tR = 8.1 min).   94 
HN
 
 
(±)-N-(1-phenylethyl)cyclohexanamine 190h 
1H NMR (400 MHz, CDCl3) ʴ 0.91-2.29 
(m, 11H), 1.34 (d,  J  =  6.8 Hz, 3H), 3.93 (q,  J = 6.8 Hz, 1H), 7.16-7.29 (m, 5H) in 
agreement with the literature data.
90 The racemic nature was confirmed by running the 
NMR spectrum in the presence of mandelic acid (2 equiv). 
 
HN
 
 
(±)-N-(1-phenylethyl)butan-1-amine 190i. 
1H NMR (400 MHz, CDCl3) ʴ 0.79 (t, J = 7.3 
Hz, 3H), 1.19 (m, 2H), 1.32 (d, J = 7.2 Hz, 3H), 1.36 (m, 2H), 2.40 (m, 2H), 3.73 (q, J = 
6.6  Hz,  1H),  7.1-7.3  (arom,  5H)  in  agreement  with  the  literature  data.
84  The  racemic 
nature was confirmed by running the NMR spectrum in the presence of mandelic acid (2 
equiv). 
 
HN
 
 
N-benzyl-1-phenylethanamine 190j. 
1H NMR (400 MHz, CDCl3) ʴ 1.30 (d, J = 7.1 Hz, 
3H), 2.13 (br s, 1H), 3.53 (m, 2H), 3.73 (q, J = 5.5 Hz, 1H), 7.1-7.3 (arom, 10H) in 
agreement  with  the  literature  data.
60,89  The  almost  racemic  nature  was  confirmed  by 
running the NMR spectrum in the presence of mandelic acid (2 equiv). 
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(S)-(–)-N-phenyl-N-(4-phenylbut-3-en-2-yl)acetamide 233a. [ʱ]D -17.4 (c 1.0, CHCl3) 
[lit.
91 gives +4.4 (c 1.0, CHCl3) for the (R)-enantiomer]; 
1H NMR (400 MHz, CDCl3) ʴ   95 
1.32 (d, J = 6.64 Hz, 3H), 3.63 (br s, 1H), 4.05 (m, 1H), 6.13 (dd, J = 5.80 Hz, J = 15.96 
Hz, 1H), 6.50 (d, J = 15.96 Hz, 1H), 6.56-7.28 (m, 10H) in agreement with the literature 
data;
91,92, For the ee determination, amine 233 was converted into the acetyl derivative by 
heating at reflux with acetyl chloride (3 equiv), triethylamine (3 equiv) and DMAP (cat.) 
in  CHCl3  for  30  min.  Aqueous  work  up  followed  by  purification  using  column 
chromatography on silica gel with a petroleum ether-ethyl acetate mixture (2:1) afforded 
the acetamide derivative as an oil: 
1H NMR (400 MHz, CDCl3) ʴ 1.16 (d, J = 6.5 Hz, 3H), 
1.72 (s, 3H), 5.55 (q, J = 6.7 Hz, 1H), 6.04 (dd, J = 5.8, 15.9 Hz, 1H), 6.40 (d, J = 15.9 
Hz, 1H) 7.03-7.34 (m, 10H); chiral HPLC (Chiralcel OD-H, hexane/2-propanol 85:15, 1.0 
mL/min) showed 74% ee (tS = 17.5 min, tR = 36.8 min).  
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(R)-(–)-methyl-2-phenyl-2-(phenylamino)acetate 234a. [ʱ]D -20.2 (c 1.0, CHCl3), -13.2 
(c 1.0, THF) [lit.
93 gives +68.3 (c 0.32, THF) for the (S)-enantiomer]; 
1H NMR (400 MHz, 
CDCl3) ʴ 3.66 (s, 3H), 4.87 (br s, 1H), 5.01 (d, J = 5.6 Hz, 1H), 6.47 (d, J = 8.4 Hz, 2H), 
6.62 (t, J = 6.8 Hz, 1H), 7.05 (t, J = 7.6 Hz, 2H), 7.24-7.31 (m, 3H), 7.43 (d, J = 7.6 Hz, 
2H)  in  agreement  with  the  literature  data;
93  chiral  HPLC  (Chiralcel  OD-H,  hexane/2-
propanol 99:1, 1 mL/min) showed 30% ee (tS = 19.5 min, tR = 23.1 min).  
 
Protocol B: General Procedure for the Synthesis of Formamides: The BOC 
derivative (1.03 mmol) was dissolved in trifluoroacetic acid (2.0 mL) at room temperature. 
After 1 hour the reaction mixture was evaporated in vacuo, the residue (the free amine) 
was dissolved in formic acid (1.5 mL) and the resulting solution was cooled to 0 
oC. 
Acetic anhydride (0.68 mL, 7.21 mmol) was added dropwise and the mixture was allowed 
to  stir  at  room  temperature  overnight.  The  volatiles  were  then  removed  by  reduced 
pressure. Purification using column chromatography on silica gel with a petroleum ether-
ethyl  acetate  mixture  (2:1)  afforded  the  desired  product;  the  yields  are  give  below. 
Formylation of amine 204 (1.03 mmol) in the same fashion (skipping the deprotection 
step) furnished 197e. 
   96 
Protocol C: General Procedure for the Synthesis of N-Methyl BOC-Protected 
Amino Acids Sodium hydride (60% dispersion  in mineral oil; 3.0 g, 138 mmol) was 
added in small portions to a stirred solution of the respective BOC-protected amino acid 
(13.8 mmol) and methyl iodide (19.6 g, 138 mmol) in anhydrous THF (60 mL) at 0 
oC. 
The mixture was allowed to stir at room temperature for 24 h under an argon atmosphere, 
the reaction was then quenched with water (15 mL), ethyl acetate (10 mL) was added and 
the mixture was evaporated in vacuo. The concentrate was diluted with water (300 mL) 
and washed with ethyl acetate (150 mL). The aqueous solution was acidified to pH 3.5 
with a solution of 5% citric acid and extracted with ethyl acetate (200 mL). The extract 
was washed with brine, dried over anhydrous MgSO4, and evaporated in vacuo to give the 
desired product; the yields are given below. 
 
Protocol  D:  General  Procedure  for  the  Synthesis  of  Amides.  Methyl 
chloroformate (0.55 mL, 7.15 mmol) was added dropwise to a stirred solution of (S)-100 
(1.40 g, 6.05 mmol) and triethylamine (1.0 mL, 7.15 mmol) in anhydrous THF (30 mL) at 
0 
oC under an argon atmosphere and the mixture was stirred at that temperature for 2 h. 
The precipitate was removed by suction filtration and the filtrate was added dropwise to a 
solution of the corresponding amine (8.5 mmol) and triethylamine (1.0 mL, 7.15 mmol) in 
anhydrous THF (30 mL) at 0 
oC. The mixture was allowed to stir at room temperature 
overnight under an argon atmosphere and the solvent was then removed under reduced 
pressure. The residue was  purified using column chromatography on silica gel  with  a 
petroleum ether-ethyl acetate mixture (4:1) to afford the desired product; the yields are 
given below. 
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(S)-(–)-3-methyl-2-(N-methylformamido)-N-phenylbutanamide  197a.  Obtained  from 
(S)-200a using protocol B (oil, 180 mg, 75%): [ʱ]D -187.0 (c 1.0, CHCl3); 
1H NMR (400 
MHz, CDCl3) ʴ 0.85 (H-1, d, J = 6.6 Hz, 3H), 0.99 (H-1, d, J = 6.7 Hz, 3H), 2.40 (H-2, m, 
1H), 2.92 (H-4, s, 3H), 4.41 (H-3, d, J = 10.3 Hz, 1H), 7.0 (Ar-H, t, J = 7.4 Hz, 1H), 7.22 
(Ar-H, t, J = 7.8 Hz, 2H), 7.46 (Ar-H, d, J = 7.7 Hz, 2H), 8.09 (H-6, s, 1H), 8.50 (H-8, br 
s, 1H); 
13C NMR ʴ 17.59 (C-1, CH3), 17.78 (C-1, CH3), 18.49 (C-4, CH3), 24.47 (C-2, 
CH), 30.60 (C-3, CH), 118.95 (Ar-C, CH), 123.39 (Ar-C, CH), 127.92 (Ar-C, CH) 136.80   97 
(Ar-C, C), (CHO), 166.31 (CO); IR (Golden Gate) ν 3274 (NH), 1650 (CO) cm
-1; MS m/z 
(%) 234 (M
•+, 8), 142 (20), 114 (35), 85 (65), 47 (15);  HRMS (EI) 234.1368 (C13H18O2N2 
requires 234.1367). 
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(S)-(–)-N-(3,5-dimethoxyphenyl)-3-methyl-2-(N-methylformamido)butanamide  197b. 
Obtained from (S)-200b using protocol B (oil, 131 mg, 26%): [ʱ]D 137.5 (c 1.0, CH2Cl2); 
1H NMR (400 MHz, CDCl3) ʴ 0.94 (H-1, d, J = 6.7 Hz, 3H), 1.04 (H-1, d, J = 6.8 Hz, 
3H), 2.49 (H-2, m, 1H), 3.02 (H-4, s, 3H), 3.79 (H-13, s, 6H), 4.38 (H-3, d, J = 11.2 Hz, 
1H), 6.25 (Ar-H, s, 1H), 6.78 (Ar-H, s, 2H), 8.04 (H-8, br s, 1H), 8.17 (H-6, s, 1H); 
13C 
NMR ʴ 18.89 (C-1, CH3), 19.95 (C-1, CH3), 25.57 (C-4, CH3), 32.04 (C-2, CH), 55.79 (C-
3, CH), 97.5 (C-13, CH3), 98.37 (C-13, CH3), 139.73 (Ar-C, CH), 161.42 (COMe), 164.50 
(CHO), 167.52 (CO); IR (NaCl) ν 3293 (NH), 1655 (CO) cm
-1; MS m/z (%) 294 (M
•+, 4), 
280    (41),  220  (3),  192  (11),  153  (100),  100  (40),  55  (19);    HRMS  (EI)  294.1580 
(C15H22O4N2 requires 294.1582). 
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(S)-(–)-N-(3,5-dimethylphenyl)-3-methyl-2-(N-methylformamido)butanamide  197c. 
Obtained from (S)-200c using protocol B (142 mg, 82%): mp 83-86 
oC; [ʱ]D -19.2 (c 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) ʴ 0.84 (H-1, d, J = 6.6 Hz, 3H), 0.99 (H-1, d, J = 6.5 
Hz, 3H), 2.20 (H-13, s, 6H), 2.39 (H-2, m, 1H), 2.95 (H-4, s, 3H), 4.35 (H-3, d, J = 11.2 
Hz, 1H), 6.67 (Ar-H, s, 1H), 7.09 (Ar-H, d, J = 8.3 Hz, 2H), 8.07 (H-6, s, 1H), 8.18 (H-8, 
br s, 1H); 
13C NMR ʴ 18.97 (C-1, CH3), 19.92 (C-13, CH3), 21.71 (C-4, CH3), 25.74 (C-2, 
CH), 63.47 (C-3, CH), 118.21 (Ar-C, CH), 126.56 (Ar-C, CH), 137.92 (C), 139.13 (C), 
164.35 (CHO), 167.61 (CO);  IR (Golden Gate) ν 3284 (NH), 1650 (CO) cm
-1; MS m/z 
(%) 262 (M
•+, 29), 160 (7), 142 (43), 114 (100), 86 (21), 83 (19), 42 (7); HRMS (EI) 
262.1681 (C15H22O2N2 requires 262.1680).    98 
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(S)-(–)-N-(3,5-bis(trifluoromethyl)phenyl)-3-methyl-2-(N-
methylformamido)butanamide  197e.  Obtained using protocol B from the  free amine 
(S)-204 so that no BOC deprotection was required prior to the formylation (189 mg, 95%): 
mp 152-154 
oC; [ʱ]D –81.5 (c 1.5, CH2Cl2); 
1H NMR (400 MHz, CDCl3) ʴ 0.89 (H-1, d, J 
= 6.6 Hz, 3H), 1.03 (H-1, d, J = 6.6 Hz, 3H), 2.45 (H-2, m, 1H), 2.96 (H-4, s, 3H), 4.34 
(H-3, d, J = 11.3 Hz, 1H), 7.52 (Ar-H, s, 1H), 7.95 (Ar-H, s, 2H), 8.10 (H-6, s, 1H), 8.90 
(H-8, br s, 1H); 
13C NMR ʴ 19.06 (C-1, CH3), 19.85 (C-1, CH3), 26.02 (C-4, CH3), 32.29 
(C-2, CH), 63.67 (C-3, CH), 117.80 (Ar-C, CH), 119.94 (Ar-C, CH), 139.84 (C), 164.51 
(CHO), 168.35 (CO); IR (NaCl) ν 3233 (NH), 1648 (CO) cm
-1; MS m/z (%) 370 (M
•+, 24), 
351 (65), 299 (16), 256 (15), 228 (26), 188 (8); HRMS 370.1118 (C15H16O2N2F6 requires 
370.1116).  
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(S)-(–)-N-butyl-3-methyl-2-(N-methylformamido)butanamide  197d.  Obtained  from 
(S)-200d using protocol B; purification using column chromatography on silica gel with 
an ethyl acetate-methanol mixture (9:1) afforded the product as an oil (357 mg, 51%); [ʱ]D 
-8.10 (c 1.5, CHCl3); 
1H NMR (400 MHz, CDCl3) ʴ 0.91 (H-1 and H-12, m, 9H), 1.32 (H-
11, m, 2H), 1.49 (H-10, m, 2H), 2.41 (H-2, m, 1H), 3.00 (H-4, s, 3H), 3.21 (H-9, m, 2H), 
4.24 (H-3, d, J = 11.2 Hz, 1H), 6.14 (H-8, br s, 1H), 8.15 (H-6, s, 1H); 
13C NMR ʴ 14.00 
(C-1, CH3), 18.87 (C-1, CH3), 19.86 (C-12, CH3), 20.21 (C-11, CH2), 25.68 (C-2, CH), 
27.88 (C-4, CH3) 31.68 (C-10, CH2), 39.51 (C-9, CH2), 164.41 (CHO), 169.38 (CO); IR 
(NaCl) ν 3318 (NH), 1653 (CO), 1558 cm
-1; MS m/z (%) 215 (M
•+, 100), 201 (5), 132 (8), 
114 (6), 79 (4); HRMS (EI): 215.1760  (C11H23O2N2 requires 215.1760).  
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 (S)-(–)-N-3-dimethyl-2-(N-methylformamido)-N-phenylbutanamide  203a.  Obtained 
from (S)-200e using protocol B (oil, 20 mg, 37%): [ʱ]D -104.0 (c 0.5, CHCl3); 
1H NMR 
(400 MHz, CDCl3) ʴ 0.61 (H-1, d, J = 6.7 Hz, 3H), 0.86 (H-1, d, J = 6.5, 3H), 2.37 (H-2, 
m, 1H), 2.76 (H-4, s, 3H), 3.20 (H-13, s, 3H), 4.54 (H-3, d, J = 10.9 Hz, 1H), 7.05 (Ar-H, 
t, J = 7.6 Hz, 1H), 7.30 (Ar-H, t, J = 7.8 Hz, 2H), 7.33 (Ar-H, d, J = 7.7 Hz, 2H), 7.84 (H-
6, s, 1H); 
13C NMR ʴ 18.50 (CH3), 18.77 (C-1, CH3), 27.29 (C-2, CH), 31.39 (C-4, CH3), 
38.01 (C-13, CH3), 64.21 (C-3, CH), 128.11 (Ar-C, CH), 129.16 (Ar-C, CH), 130.65 (Ar-
C, CH), 142.98 (C), 163.44 (CHO), 169.77 (CO); IR (Golden Gate) ν 1658 (CO) cm
-1; 
MS m/z (%) 248 (M
•+, 3), 142 (21), 114 (53), 83 (100), 77 (5), 47 (16); HRMS 248.1526 
(C14H20O2N2 requires 248.1525). 
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(S)-(–)-N,N-diethyl-3-methyl-2-(N-methylformamido)butanamide  203b.  Obtained 
from (S)-200f using protocol B (oil, 75 mg, 83%): [ʱ]D -11.6 (c 1.5, CHCl3); 
1H NMR 
(400 MHz, CDCl3) ʴ 0.77 (H-1, d, J = 6.7 Hz, 3H), 0.85 (H-1, d, J = 6.8 Hz, 3H), 1.09 (H-
10, m, 3H), 1.11 (H-10, m, 3H), 2.36 (H-2, m, 1H), 2.85 (H-4, s, 3H), 3.20 (H-9, m, 2H), 
3.33 (H-9, m, 2H), 4.76 (H-3, d,  J = 10.7 Hz, 1H), 8.02 (H-6, br s, 1H); 
13C NMR ʴ 13.23 
(C-1, CH3), 15.51 (C-1, CH3), 18.51 (C-10, CH3), 19.87 (C-10, CH3), 26.77 (C-2, CH), 
31.26 (C-4, CH3), 40.87 (C-9, CH2), 42.06 (C-9, CH2), 63.79 (C-3, CH), 163.23 (CHO), 
168.43 (CO); MS m/z (%) 215 (M
•+, 100), 187 (4), 142 (10), 114 (8), 81 (19); HRMS (EI): 
215.1760 (C11H23O2N2 requires 215.1761).  
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(S)-(+)-N-(3,5-dimethoxyphenyl)-2-formamido-3-methylbutanamide  207.  Obtained 
from (S)-100 using protocol B (191 mg, 60%): mp 151-153 
oC; [ʱ]D +1.2 (c 1.0, MeOH); 
1H NMR (400 MHz, CDCl3) ʴ 0.96 (H-1, d, J = 6.8 Hz, 3H), 0.98 (H-1, d, J = 6.7 Hz, 
3H), 2.12 (H-2, m, 1H), 3.69 (H-13, s, 6H), 4.50 (H-3, t, J = 7.8 Hz, 1H), 6.16 (Ar-H, s, 
1H), 6.70 (Ar-H, s, 2H), 8.21 (H-6, s, 1H), 8.37 (br s, 1H); 
13C NMR ʴ 18.76  (C-1, CH3), 
19.67  (C-1, CH3), 31.83 (C-2, CH), 55.72  (C-13, CH3), 58.44 (C-3, CH), 97.4 (Ar-C, 
CH), 98.58 (Ar-C, CH), 139.73 (C), 161.36 (C), 161.74 (CHO), 169.79 (CO); IR (NaCl) ν 
3272 (NH), 1645 (CO) cm
-1; MS (CI) m/z (%) 281 ([MH]
•+, 100), 263 (2), 192 (3); HRMS 
(CI) 281.1501 (C14H21O4N2 requires 281.1501). 
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(R)-(+)-N-(3,5-dimethylphenyl)-2-(N-methylformamido)-2-phenylacetamide  208a. 
Obtained from (R)-211a using protocol B (solid, 292 mg, 34%): mp 149-150 
oC; [ʱ]D +8.9 
(c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) ʴ 2.23 (H-13, s, 6H), 2.94 (H-4, s, 3H), 6.22 
(H-3, s, 1H), 6.80 (Ar-H, s, 1H), 7.16 (Ar-H, s, 2H), 7.43-7.47 (H-1, m, 5H), 8.26 (H-6, s, 
1H); 
13C NMR ʴ 21.04 (C-13, CH3), 28.81 (C-4, CH3), 58.34 (C-3, CH), 117.00-128.87 
(Ar-C,  CH), 134.65-138.45 (Ar-C,  C), 167.52 (CO), 168.35 (CHO);  IR (KBr) ν 3275 
(NH), 1653 (CO) cm
-1; MS m/z (%) 296 (M
•+, 24), 274 (5), 210 (1), 175 (33), 148 (100), 
120 (50), 77 (14), 42 (24); HRMS (EI) 296.1525 (C18H20O2N2 requires 296.1524). 
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(S)-(–)-N-(3,5-dimethylphenyl)-2-(N-methylformamido)-3-phenylpropanamide  208b. 
Obtained from (S)-211b using protocol B (solid, 1.50 g, 78%): mp 81-85 
oC; [ʱ]D –87.8 (c 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3, a mixture of rotamers in ca. 4:1 ratio; the signals 
for the minor rotamer are marked by *) ʴ 2.29 (H-13, s, 6H), 2.94* (s, 0.6H), 2.98 (H-5, s, 
2.4H), 3.01* (H-3, dd, J = 14.4 and 1.4 Hz, 0.2H), 3.12 (H-3, dd, J = 14.4 and 8.4 Hz, 
0.8H), 3.43 (H-3‟, dd, J = 14.4 and 7.6 Hz, 0.8H), 3.56* (H-3‟, dd, J = 14.8 and 4.4 Hz, 
0.2H), 5.25 (H-4, t, J = 8.0 Hz, 1H), 6.76 (Ar-H, s, 0.8H), 6.85* (Ar-H, s, 0.2H), 7.13 (Ar-
H, s, 1.6H), 7.18* (Ar-H, s, 0.4H), 7.28-7.36 (Ar-H, m, 5H), 8.06 (br s, 0.8H), 8.08 (s, 
0.8H), 8.37* (s, 0.2H), 8.66* (s, 0.2H); 
13C NMR ʴ 20.94 (C-13, CH3), 26.62 (C-5, CH3), 
34.78 (C-3, CH2), 62.26 (C-4, CH), 115.15-126.52 (a set of signals, Ar,-C, CH), 128.29-
138.54 (a set of signals, C), 159.42-168.36 (a set of signals, CO); IR (KBr) ν 3308 (NH), 
1703 (CO) cm
-1;  MS m/z (%) 310 (M
•+, 50), 251 (10), 190 (39), 162 (100), 134 (85), 91 
(29), 42 (15); HRMS (EI) 310.1681 (C19H22O2N2 requires 310.1682). 
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(S)-(–)-N-(3,5-dimethylphenyl)-2-(N-methylformamido)propanamide  208c.  Obtained 
from (S)-211c using protocol B (oil, 916 mg, 78%): [ʱ]D –222.6 (c 1.0, CHCl3); 
1H NMR 
(400 MHz, CDCl3) ʴ 1.46 (H-1, d, J = 7.2 Hz, 3H), 2.30 (H-12, s, 6H), 2.97 (H-3, s, 3H), 
5.08 (H-2, q, J = 7.2 Hz, 1H), 6.76 (Ar-H, s, 1H), 7.01 (Ar-H, s, 2H), 8.16 (H-5, s, 1H); 
13C NMR ʴ 12.64 (C-1, CH3), 21.35 (C-12, CH3), 30.98 (C-3, CH3), 51.29 (C-2, CH), 
117.83 (Ar-C, CH), 126.15 (Ar-C, CH), 137.50 (C), 138.01 (C), 163.87 (CHO), 168.04 
(CO); IR (NaCl) ν 3289 (NH), 1644 (CO) cm
-1;  MS m/z (%) 234 (M
•+, 33), 199 (5), 147 
(6), 113 (31), 82 (100), 58 (37), 49 (39); HRMS (EI) 234.1371 (C13H18O2N2 requires 
234.1368). 
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(S)-(–)-N-(3,5-dimethylphenyl)-4-methyl-2-(N-methylformamido)pentanamide  208d. 
Obtained from (S)-211d using protocol B (oil, 1.13 g, 84%): [ʱ]D –191.1 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) ʴ 0.98 (H-1, d, J = 6.6 Hz, 3H), 1.01 (H-1, d, J = 6.6 Hz, 
3H), 1.59 (H-2, hept, J = 6.6 Hz, 1H), 1.72 (H-3, ddd, J = 14.0, 8.0 and 6.0 Hz, 1H), 1.87-
1.94 (H-3, m, 1H), 2.30 (H-14, s, 6H), 2.90 (H-5, s, 3H), 4.99 (H-4, t, J = 8.0 Hz, 1H), 
6.76 (Ar-H, s, 1H), 7.16 (Ar-H, s, 2H), 8.03 (H-9, br s, 1H), 8.16 (H-7, s, 1H); 
13C NMR ʴ 
21.37 (C-1, CH3), 22.83 (C-14, CH3), 24.77 (C-2, CH), 31.28 (C-5, CH3), 35.61 (C-3, 
CH2), 54.07 (C-4, CH), 117.90 (Ar-C, CH), 126.31 (Ar-C, CH), 137.24 (C), 138.71 (C), 
164.12 (CHO), 167.88 (CO);  IR (NaCl) ν 3299 (NH), 1681 (CO);  MS m/z (%) 276 (M
•+, 
36),  220  (5),  176  (4),  156  (30),  128  (100),  86  (23),  58  (16);  HRMS  (EI)  276.1840 
(C16H24O2N2 requires 276.1838). 
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 (S)-(–)-1-(1-(3,5-dimethylphenylamino)-3-methyl-1-oxobutan-2-yl)-1-methyl-3-
phenylurea  206.  The BOC  derivative (S)-200c  (504 mg, 1.5 mmol) was  dissolved in 
trifluoroacetic acid (2.0 mL) at room temperature. After 1 hour the reaction mixture was 
evaporated in vacuo, the residue was dissolved in cold, dry Et2O (50 mL) and the reaction 
stirred at room temperature, under argon, for 90 minutes. Phenylisocyanate (0.22 mL, 20.9 
mmol) was then added dropwise to the solution and then allowed to stir over night at room 
temperature.  The  solvent  was  then  removed  in  vacuo.  Purification  using  column 
chromatography on silica gel with a petroleum ether-ethyl acetate mixture (1:1) afforded 
(S)-206 as a solid (292 mg, 55%): mp 131-133 
oC; [ʱ]D -158.1 (c 1.0, CHCl3); 
1H NMR 
(400 MHz, CDCl3) ʴ 0.87 (H-1, d, J = 6.4 Hz, 2H), 0.98 (H-1, d, J = 6.4 Hz, 2H), 2.21 (H-
15, s, 6H), 2.34 (H-2, m, 1H), 2.98 (H-4, s, 3H), 4.33 (H-3, d, J = 11.6 Hz, 1H), 6.66 (Ar-
H, s, 1H), 7.01 (Ar-H, t, J = 7.4 Hz, 1H), 7.07 (Ar-H, s, 2H), 7.32(Ar-H, t, J = 5.6 Hz, 
2H), 7.34 (Ar-H, d, J = 7.6 Hz, 2H), 8.15 (H-10, br s, 1H); 
13C NMR ʴ 18.82 (C-1, CH3),   103 
19.87 (C-15, CH3), 21.38 (C-4, CH3), 26.33 (C-2, CH), 117.52 (Ar-C, CH), 120.32 (Ar-C, 
CH), 121.26 (Ar-C, CH), 123.75 (Ar-C, CH), 124.41 (Ar-C, CH), 125.99 (Ar-C, CH), 
129.04 (Ar-C, CH), 129.39 (Ar-C, CH), 137.74 (C), 138.60 (C), 138.74 (C), 156.91 (CO), 
168.87 (CO); IR (KBr) ν 3272 (NH), 1644 (CO); MS m/z (%) 353 (M
•+, 10), 232 (33), 205 
(19), 160 (5), 121 (48), 86 (100), 84 (18), 49 (17); HRMS (EI) 353.2106 (C21H27O2N3 
requires 353.2103). 
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(S)-2-(tert-Butoxycarbonyl-methyl-amino)-3-methyl-butyric  Acid  (S)-199.  Obtained 
from (S)-198 as an oil (3.15 g, 13.6 mmol, 98%) using protocol C; this product was used 
in the following step without further purification: 
1H NMR (400 MHz, CDCl3) ʴ 0.93 (d, J 
= 6.7 Hz, 3H), 1.05 (d, J = 6.6 Hz, 3H), 1.49 (s, 9H), 2.39 (m, 1H), 2.90 (s, 3H), 4.01 (d, J 
= 10.4 Hz, 1H), in agreement with literature.
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(S)-tert-butylmethyl(3-methyl-1-oxo-1-(phenylamino)butan-2-yl)carbamate  200a. 
Obtained from (S)-199, using protocol D (oil, 803 mg, 43%): 
1H NMR (400 MHz, CDCl3) 
ʴ 0.85 (d, J = 6.7 Hz, 3H), 0.97 (d, J = 6.4 Hz, 3H), 1.43 (s, 9H), 2.32 (m, 1H), 2.75 (s, 
3H), 4.03 (d, J = 10.2 Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 7.22 (t, J = 7.8 Hz, 2H), 7.44 (d, J 
= 7.8 Hz, 2H), 8.19 (br s, 1H); 
13C NMR ʴ 18.99 (CH3), 20.30 (CH3), 26.24 (CH3), 28.76 
(CH3), 30.94 (CH3), 66.70 (C), 81.10 (C), 120.06 (CH), 124.48 (CH), 129.37 (CH), 138.45 
(C), 169.18 (CO);  IR (Golden Gate) ν 3311 (NH), 1658 (CO) cm
-1; MS m/z (%) 306 (M
+, 
6%)  214  (7),  186  (14),  130  (71),  83  (100),  57  (39),  47  (17);  HRMS  (EI):  306.1943 
(C17H26O3N2 requires 306.1943). 
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 (S)-tert-butyl-1-(3,5-dimethoxyphenylamino)-3-methyl-1-oxobutan-2-
yl(methyl)carbamate 200b. Obtained from (S)-199, using protocol D (oil, 451 mg, 29%): 
1H NMR (400 MHz, CDCl3) ʴ 0.82 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 6.7 Hz, 3H), 1.39 (s, 
9H), 2.95 (m, 1H), 2.75 (s, 3H), 3.70 (s, 6H), 4.00 (m, 1H), 6.15 (s, 1H), 6.68 (s, 2H), 8.18 
(br s, 1H). 
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 (S)-tert-butyl-1-(3,5-dimethylphenylamino)-3-methyl-1-oxobutan-2-
yl(methyl)carbamate  200c.  Obtained  from  (S)-199,  using  protocol  D;  purification  by 
column chromatography on silica gel with a petroleum ether-ethyl acetate mixture (24:1) 
afforded pure product as an oil (240 mg, 70%): 
1H NMR (400 MHz, CDCl3) ʴ 0.77 (d, J = 
6.5 Hz, 3H), 0.88 (d, J = 6.5 Hz, 3H), 1.38 (s, 9H), 2.17 (s, 6H), 2.25 (m, 1H), 2.76 (s, 
3H), 4.08 (d, J = 10.8 Hz, 1H), 6.62 (s, 1H), 7.07 (s, 2H), 8.24 (br s, 1H). 
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 (S)-tert-butyl-1-(butylamino)-3-methyl-1-oxobutan-2-yl(methyl)carbamate  200d. 
Obtained  from  (S)-199,  using  protocol  D;  purification  by  column  chromatography  on 
silica gel with a petroleum ether-ethyl acetate mixture (3:1) afforded a pure product as an 
oil (928 mg, 61%): 
1H NMR (400 MHz, CDCl3) ʴ 0.80 (m, 9H), 1.29 (m, 2H), 1.39 (s, 
9H), 2.20 (m, 1H), 2.73 (s, 3H), 3.17 (m, 2H), 3.90 (d, J = 10.9 Hz, 1H), 6.04 (br s, 1H). 
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(S)-N-(3,5-bis(trifluoromethyl)phenyl)-3-methyl-2-(methylamino)butanamide  204. 
Following a literature protocol,
95 a solution of pivaloyl chloride (1.1 mL, 8.6 mmol) in 
anhydrous THF (8 mL) was added dropwise to a stirred solution of (S)-199 (2.0 g, 8.6 
mmol) and triethylamine (1.2 mL, 8.6 mmol) in anhydrous THF (16 mL) at –15 
oC.  The 
solution was then warmed to 0 
oC and allowed to stir at this temperature for 5 min.  The 
solution was then cooled again to –15 
oC and a solution of 3,5-bis(trifluoromethyl)-aniline 
(1.34 mL) in anhydrous THF (8 mL) was added dropwise and the mixture was stirred at 0 
oC for 1 h.  The mixture was then warmed to room temperature and stirring was continued 
for  27  h  under  an  argon  atmosphere.  The  solvent  was  then  removed  under  reduced 
pressure, the residue was diluted with water (20 mL) and then extracted with ethyl acetate 
(20 mL). The extracts were washed with brine, dried over MgSO4, and concentrated under 
reduced  pressure.  Purification  using  column  chromatography  on  silica  gel  with  a 
petroleum ether-ethyl acetate mixture (1:1) afforded (S)-204 as an oil (185 mg, 7%): 
1H 
NMR (400 MHz, CDCl3) ʴ 0.87 (d, J = 6.9 Hz, 3H), 0.99 (d, J = 7.0 Hz, 3H), 2.15 (m, 
1H), 2.42 (s, 3H), 2.87 (d, J = 4.24Hz, 1H), 7.50 (s, 1H), 8.05 (s, 2H), 9.69 (br s, 1H). 
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(R)-2-(tert-butoxycarbonyl)-2-phenylacetic acid 210a. Obtained from (R)-209a as an oil 
(2.33 g, 78%) using protocol C; this product was used in the following step without further 
purification: 
1H NMR (400 MHz, CDCl3) ʴ 1.42 (s, 9H), 2.62 (s, 3H), 7.21-7.45 (m, 5H). 
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(S)-2-(tert-butoxycarbonyl)-3-phenylpropanoic acid 210b. Obtained from (S)-209a as 
an oil (2.38 g, 71%) using protocol C; this product was used in the following step without 
further purification: 
1H NMR (400 MHz, CDCl3 a mixture of rotamers in ca 1:1 ratio) ʴ 
1.23 (s, 4.5H), 1.33 (s, 4.5H), 2.52 (s, 1.5H), 2.59 (s, 1.5H), 2.90 (m, 1H), 3.11 (m, 1H), 
4.44 (dd, J = 4.0 and 10.4 Hz, 0.5H), 4.65 (dd, J = 5.2 and 10.8 Hz, 0.5H), 7.01-7.21 (m, 
5H). 
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(S)-2-(tert-butoxycarbonyl)propanoic acid 210c. Obtained from (S)-209c as an oil (4.90 
g, 98%) using protocol C; this product was used in the following step without further 
purification: 
1H NMR (400 MHz, CDCl3) ʴ 1.37 (d, J = 6.7 Hz, 3H), 1.40 (s, 9H), 2.89 (s, 
3H), 4.19 (m, 1H).  
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(S)-2-(tert-butoxycarbonyl)-4-methylpentanoic acid 210d. Obtained from (S)-209d as 
an oil (2.60 g, 72%) using protocol C; this product was used in the following step without 
further purification: 
1H NMR (400 MHz, CDCl3) ʴ 0.87 (d, J = 6.8 Hz, 3H), 0.89 (d, J = 
6.8 Hz, 3H), 1.39 (s, 9H), 1.49 (m, 1H), 1.66 (m, 1H), 2.73 (s, 3H), 4.73 (m, 1H). 
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(R)-tert-butyl-2-(3,5-dimethylphenylamino)-2-oxo-1-phenylethyl(methyl)carbamate 
211a. Obtained from (R)-210a, using protocol D; purification by column chromatography 
on silica gel with a petroleum ether-ethyl acetate mixture (1:1) afforded a pure product as 
an oil (2.01g, 56%): 
1H NMR (400 MHz, CDCl3) ʴ 1.42 (s, 9H), 2.22 (s, 6H), 2.72 (s, 3H), 
5.88 (br s, 1H), 6.69 (s, 1H), 7.09 (s, 2H), 7.23-7.46 (m, 5H).  
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(S)-tert-butyl-1-(3,5-dimethylphenylamino)-1-oxo-3-phenylpropan-2-
yl(methyl)carbamate 211b. Obtained from (S)-210b, using protocol D; purification by 
column chromatography on silica gel with a petroleum ether-ethyl acetate mixture (1:1) 
afforded a pure product as an oil (2.38g, 94%): 
1H NMR (400 MHz, CDCl3) ʴ 1.42 (s, 
9H), 2.22 (s, 6H), 2.80 (s, 3H), 3.10 (dd, J = 14 and 8.2 Hz, 1H), 3.38 (dd, J = 14 and 6.8 
Hz, 1H), 4.98-5.01 (m, 1H), 6.74 (s, 1H), 7.12 (s, 2H), 7.15-7.32 (m, 5H), 8.11 (br s, 1H). 
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(S)-tert-butyl-1-(3,5-dimethylphenylamino)-1-oxopropan-2-yl(methyl)carbamate 
210c. Obtained from (S)-211c, using protocol D; purification by column chromatography 
on silica gel with a petroleum ether-ethyl acetate mixture (2:1) afforded a pure product as 
an oil (1.54 g, 93%): 
1H NMR (400 MHz, CDCl3) ʴ 1.32 (d, J = 7.2 Hz, 3H), 1.43 (s, 9H), 
2.26 (s, 6H), 2.74 (s, 3H), 4.75 (bs, 1H), 6.67 (s, 1H), 7.07 (s, 2H), 8.12 (br s, 1H).   108 
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(S)-tert-butyl-1-(3,5-dimethylphenylamino)-4-methyl-1-oxopentan-2-
yl(methyl)carbamate 210d. Obtained from (S)-211d, using protocol H; purification by 
column chromatography on silica gel with a petroleum ether-ethyl acetate mixture (2:1) 
afforded a pure product as an oil (1.70 g, 75%): 
1H NMR (400 MHz, CDCl3) ʴ 0.88 (d, J = 
6.4 Hz, 3H), 0.91 (d, J = 6.4 Hz, 3H), 1.43 (s, 9H), 1.46-1.54 (m, 1H), 1.56-1.64 (1H, m), 
1.69-1.82 (m, 1H), 2.26 (s, 6H), 2.71 (s, 3H), 4.66 (br s, 1H), 6.67 (s, 1H), 7.06 (s, 2H), 
8.05 (br s, 1H). 
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(S)-tert-butyl-1-(3,5-dimethoxyphenylamino)-3-methyl-1-oxobutan-2-ylcarbamate 
200b. Obtained from (S)-198, using protocol D; purification by column chromatography 
on silica gel with a petroleum ether-ethyl acetate mixture (1:1) afforded a pure product as 
an oil (309 mg, 19%): 
1H NMR (400 MHz, CDCl3) ʴ 0.84 (d, J = 6.8 Hz, 3H), 0.93 (d, J = 
6.8 Hz, 3H), 1.39 (s, 9H), 2.90 (m, 1H), 3.70 (s, 6H), 3.90 (t, J = 6.4 Hz, 1H), 4.98 (br s, 
1H), 6.16 (s, 1H), 6.69 (s, 2H), 7.78 (br s, 1H). 
 
General Procedure for the Allylation of Aldehydes   
 
Allyltrichlorosilane (11.8 mmol) was added drop wise to a stirred solution of aldehyde 
(9.4  mmol),  anhydrous  DMF  (6  mL)  in  anhydrous  CH2Cl2  (30  mL)  at  0 
oC,  and  the 
mixture allowed to stir overnight at room temperature under an atmosphere of nitrogen. 
The reaction was then quenched with a saturated aqueous solution of NaHCO3 (10 mL) 
and the product extracted with ethyl acetate (50 mL). The extract was washed with brine 
and dried over anhydrous MgSO4 and the solvent removed in vacuo. Purification using   109 
column chromatography on silica gel with a petroleum ether-ethyl acetate mixture (5:1) 
afforded the product as an oil. 
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1-phenylbut-3-en-1-ol 248a: (89%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 2.08 (s, 1H), 2.37-
2.49 (m, 2H), 4.62-4.66 (m, 1H), 5.05-5.15 (m, 2H), 5.68-5.78 (m, 1H), 7.17-7.29 (m, 
5H); MS m/z (%) 148 (M
•+, 2), 128 (3), 107 (99), 79 (80), 51 (12) in agreement with 
literature data. 
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2-(1-hydroxybut-3-enyl)phenol 248b: (10%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 2.58-
2.69 (m, 2H), 2.66 (bs, 1H), 4.89-4.93 (m, 1H), 5.24-5.30 (m, 2H),  5.81-5.94 (m, 1H), 
6.83-6.91 (m, 2H), 7.01 (dd, J = 7.56, 1.56 Hz, 1H), 7.19-7.25 (m, 1H), 8.04 (bs, 1H); MS 
m/z (%) 164 (M
•+, 10), 145 (11), 123 (99), 95 (33), 77 (41), 39 (15) in agreement with 
literature data 
98 
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1-(3-methoxyphenyl)but-3-en-1-ol 248c: (25%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 2.06 
(bs, 1H), 2.46-2.59 (m, 2H), 3.88 (s, 3H), 4.73-4.76 (m, 1H), 5.16-5.23 (m, 2H), 5.79-5.89 
(m, 1H), 6.82-6.85 (m, 1H), 6.95-6.97 (m, 2H), 7.21-7.33 (m, 1H); MS m/z (%) 178 (M
•+, 
10), 152 (1), 137 (91), 109 (99), 94 (29), 77 (32), 28 (12) in agreement with literature data 
99 
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1-(3-chlorophenyl)but-3-en-1-ol 248d: (49%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 2.02 
(bs, 1H), 2.44-2.58 (m, 2H), 4.74-4.77 (m, 1H), 5.18-5.23 (m, 2H), 5.76-5.87 (m, 1H), 
7.30-7.36 (m, 4H); MS m/z (%) 182 (M
•+, 1), 178 (1), 141 (99), 139 (9), 113 (20), 77 (72), 
28 (18) in agreement with literature data 
100 
 
General Procedure for Grignard Reaction: 
 
To a suspension of magnesium turnings (16.3 mmol) in anhydrous Et2O (5 mL) was added 
a solution of 5-bromopent-1-ene (or 4-bromobut-1-ene) (14.8 mmol) in anhydrous Et2O 
(50 mL) and the resulting solution refluxed for 1 hour.  The mixture was then cooled to -
10 
oC and too this was added aldehyde (15.5 mmol) drop wise, keeping the temperature 
below -5 
oC.  The reaction mixture was then slowly brought to room temperature and then 
poured into ice (100 g) and H2SO4 (15 mL).  This was extracted with Et2O (2 x 50 mL) 
and  the  organic  layers  dried  over  anhydrous  MgSO4  and  concentrated  in  vacuo.  
Purification  using  column  chromatography  on  silica  gel  with  a  petroleum  ether-ethyl 
acetate mixture (8:1) afforded the product as an oil. 
101  
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1-phenylhex-5-en-1-ol 253a: (67%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 1.32-1.49 (m, 1H), 
1.51-1.62 (m, 1H), 1.71-1.90 (m, 2H), 2.04-2.15 (m, 2H), 4.69-4.73 (m, 1H), 4.96-5.05 
(m, 2H), 5.78-5.87 (m, 1H), 7.29-7.47 (m, 5H);  MS m/z (%) 178 (M
•+, 2), 133 (20), 107 
(99), 105 (15), 79 (61), 41 (9), 28 (17) in agreement with literature data 
102 
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2-(1-hydroxyhex-5-enyl)phenol 253b: (8%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 1.01-1.10 
(m, 1H), 1.12-1.24 (m, 1H), 1.29-1.38 (m, 1H), 1.42-1.56 (m, 1H), 1.69-1.80 (m, 1H), 
1.81-1.92 (m, 1H), 2.50 (bs, 1H), 4.72-4.78 (m, 1H), 4.84-4.98 (m, 2H), 5.66-5.88 (m, 
1H), 6.72-7.09 (m, 4H), 7.81 (bs, 1H);  MS m/z (%) 194 (M
•+, 1), 192 (35), 174 (73), 145 
(32), 123 (99), 95 (64), 65 (22), 27 (12) in agreement with literature data 
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1-(3-methoxyphenyl)hex-5-en-1-ol 253c: (45%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 1.37-
1.48 (m, 1H), 1.52-1.61 (m, 1H), 1.71-1.87 (m, 3H), 2.07-2.13 (m, 2H), 3.85 (s, 3H), 4.67-
4.70 (m, 1H), 4.95-5.05 (m, 2H), 5.76-5.87 (m, 1H), 6.83-6.86 (m, 1H), 6.93-6.96 (m, 
2H), 7.27-7.31 (m, 1H);  MS m/z (%) 208 (M
•+, 2), 175 (4), 163 (22), 137 (81), 109 (99), 
77 (29), 65 (10), 28 (21) in agreement with literature data 
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OH
Cl   
 
1-(3-chlorophenyl)hex-5-en-1-ol 253d: (68%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 1.38-
1.47 (m, 1H), 1.49-1.61 (m, 1H), 1.67-1.83 (m, 2H), 1.89 (bs, 1H), 2.05-2.11 (m, 2H), 
4.67-4.71 (m, 1H), 4.94-5.05 (m, 2H), 5.76-5.86 (m, 1H), 7.20-7.36 (m, 4H);  
13C NMR ʴ 
24.92 (CH2), 33.68 (CH2), 38.63 (CH2), 73.91 (CH), 114.46 (CH2), 124.50 (CH), 126.39 
(CH), 128.31 (CH), 129.69 (CH), 134.46 (C), 138.35 (CH), 147.04 (C); IR (NaCl) ν 3439 
(OH), 997 (RHC=CH2); MS m/z (%) 210 (M
•+, 13), 192 (3), 167 (48), 141 (99), 139 (23), 
113 (68), 75 (10), 41 (21), 39 (18); HRMS (EI) 210.0812 (C12H15OCl requires 210.0811). 
 
 
   112 
OH
 
 
1-phenylpent-4-en-1-ol 252a: (19%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 1.78-1.98 (m, 
2H), 2.07-2.25 (m, 2H), 4.71-4.75 (m, 1H), 4.99-5.10 (m, 2H), 5.81-5.92 (m, 1H), 7.18-
7.47 (m, 5H); MS m/z (%) 162 (M
•+, 3), 144 (7), 120 (21), 107 (69), 105 (12), 79 (47), 77 
(30), 51 (8) in agreement with literature data 
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OH
OMe  
 
1-(3-methoxyphenyl)pent-4-en-1-ol  252c:  (64%,  oil) 
1H  NMR  (400  MHz,  CDCl3)  ʴ 
1.67-1.86 (m, 3H), 1.95-2.13 (m, 2H), 3.75 (s, 3H), 4.59-4.63 (m, 1H), 4.84-4.98 (m, 2H), 
5.69-5.83 (m, 1H), 6.73-7.75 (m, 1H), 6.84-6.87 (m, 2H), 7.15-7.18 (m, 1H); MS m/z (%) 
192 (M
•+, 27), 163 (3), 137 (96), 109 (99), 77 (44), 65 (15), 39 (15) in agreement with 
literature data 
10 
 
General Procedure for PCC
* Oxidation: 
 
To a solution of alcohol (3.48 mmol) in CH2Cl2 (30 mL) was added PCC (7.31 mmol) and 
the mixture allowed to stir, at room temperature for ~3 hours.  Et2O (15 mL) was then 
added and stirred for a further 15 minutes.  The reaction mixture was then filtered through 
a short pad of silica, washed with Et2O (~15 mL) and concentrated in vacuo to afford the 
corresponding ketone  as  an oil (unless  otherwise stated).  No further purification was 
required. 
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O
 
 
1-phenylbut-3-en-1-one 249a: (42%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 3.69-3.71 (m, 
2H), 5.13-5.19 (m, 2H), 5.97-6.08 (m, 1H), 7.36-7.42 (m, 2H), 7.55-7.59 (m, 1H), 7.89-
7.92 (m, 2H) in agreement with literature data. 
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* Pyridinium Chlorochromate   113 
O
Cl  
 
1-(3-chlorophenyl)but-3-en-1-one 249d: (70%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 3.75-
3.78 (m, 2H), 5.22-5.29 (m, 2H), 6.05-6.15 (m, 1H), 7.46-7.49 (m, 2H), 7.92-7.96 (m, 
2H); 
13C NMR ʴ 43.43 (CH2), 119.04 (CH2), 128.86 (CH x2), 129.95 (CH), 130.93 (CH), 
134.67 (C), 139.67 (C), 196.82 (CO); IR (KBr) ν 1682 (C=O), 921 (RCH=CH2); MS m/z 
(%) 180 (M
•+, 18), 139 (98), 111 (52), 83 (39), 75 (40), 49 (61), 39 (17); HRMS (EI) 
180.0348 (C10H9OCl requires 180.0342).    
 
O
 
 
1-phenylpent-4-en-1-one 254a: (71%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 2.50-2.56 (m, 
2H), 3.09-3.13 (m, 2H), 5.03-5.33 (m, 2H), 5.89-5.99 (m, 1H), 7.49-7.51 (m, 2H), 7.57-
7.61 (m, 1H), 7.99-8.12 (m, 2H); MS m/z (%) 160 (M
•+, 4), 145 (2), 129 (2), 105 (99), 82 
(55), 77 (41), 51 (12), 46 (15). in agreement with literature data
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O
 
 
1-phenylhex-5-en-1-one 255a: (54%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 1.73-1.82 (m, 
2H), 2.05-2.11 (m, 2H), 2.89-2.93 (m, 2H), 4.90-4.99 (m, 2H), 5.72-5.81 (m, 1H), 7.35-
7.41 (m, 2H), 7.43-7.51 (m, 1H), 7.86-7.90 (m, 2H); MS m/z (%) 174 (M
•+, 10), 133 (4), 
105 (99), 77 (52), 51 (15), 28 (19) in agreement with literature data. 
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O
OMe  
 
1-(3-methoxyphenyl)hex-5-en-1-one  255c:  (91%,  oil) 
1H  NMR  (400  MHz,  CDCl3)  ʴ 
1.84-1.91 (m, 2H), 2.16-2.21 (m, 2H), 2.97-3.01 (m, 2H), 3.89 (s, 3H), 5.02-5.06 (m, 2H),   114 
5.80-5.90 (m, 1H), 7.13 (dd, J = 2.0, 8.4 Hz, 1H), 7.37-7.41 (m, 1H), 7.51-7.52 (m, 1H), 
7.55-7.57 (m, 1H); MS m/z (%) 204 (M
•+, 23), 175 (1), 150 (99), 135 (81), 107 (40), 77 
(37), 64 (12), 28 (28); HRMS (EI) 204.1151 (C13H16O2 requires 204.1150).  in agreement 
with literature data 
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O
Cl  
 
1-(3-chlorophenyl)hex-5-en-1-one 255d: (72%, oil) 
1H NMR (400 MHz, CDCl3) ʴ 1.84-
1.91 (m, 2H), 2.16-2.21 (m, 2H), 2.96-3.00 (m, 2H), 5.02-5.11 (m, 2H), 5.79-5.89 (m, 
1H), 7.41-7.45 (m, 1H), 7.52-7.57 (m, 1H), 7.85-7.87 (m, 1H), 7.94-7.95 (m, 1H); 
13C 
NMR ʴ 23.11 (CH2), 33.10 (CH2), 37.80 (CH2), 115.49 (CH2), 126.12 (CH), 128.19 (CH), 
129.94 (CH), 132.88 (CH), 134.93 (C), 137.90 (CH), 138.60 (C), 198.89 (CO); IR (NaCl) 
ν 1690 (C=O), 913 (RCH=CH2); MS m/z (%) 209/211 (M+H, 51/19), 193 (8), 157 (8), 
125 (6), 113 (32), 85 (45), 73 (99); HRMS (EI) 209.0733 (C12H14OCl requires 209.0734). 
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